JP2017535561A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017535561A5 JP2017535561A5 JP2017526957A JP2017526957A JP2017535561A5 JP 2017535561 A5 JP2017535561 A5 JP 2017535561A5 JP 2017526957 A JP2017526957 A JP 2017526957A JP 2017526957 A JP2017526957 A JP 2017526957A JP 2017535561 A5 JP2017535561 A5 JP 2017535561A5
- Authority
- JP
- Japan
- Prior art keywords
- triazolo
- pyrrolo
- pyrimidin
- pyrazin
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 150000001875 compounds Chemical class 0.000 claims description 82
- 125000000217 alkyl group Chemical group 0.000 claims description 70
- -1 (5-methylpyrazin-2-yl) -2- (8- (3,3,4,4,4-pentafluorobutyl)-[1,2,4] Triazolo [1,5-a] pyrazin-6-yl) -5H-pyrrolo [2,3-d] pyrimidin-6 (7H) -one Chemical compound 0.000 claims description 53
- 125000005843 halogen group Chemical group 0.000 claims description 48
- 150000003839 salts Chemical class 0.000 claims description 38
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 30
- 125000003118 aryl group Chemical group 0.000 claims description 22
- 125000004356 hydroxy functional group Chemical group O* 0.000 claims description 20
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 18
- 229910052739 hydrogen Inorganic materials 0.000 claims description 16
- 239000001257 hydrogen Substances 0.000 claims description 16
- 125000001072 heteroaryl group Chemical group 0.000 claims description 14
- 125000005842 heteroatom Chemical group 0.000 claims description 14
- 125000003545 alkoxy group Chemical group 0.000 claims description 12
- 125000002877 alkyl aryl group Chemical group 0.000 claims description 12
- 239000003814 drug Substances 0.000 claims description 12
- 229910052760 oxygen Inorganic materials 0.000 claims description 10
- 229910052717 sulfur Inorganic materials 0.000 claims description 10
- 206010016654 Fibrosis Diseases 0.000 claims description 8
- 206010019280 Heart failures Diseases 0.000 claims description 8
- 206010020772 Hypertension Diseases 0.000 claims description 8
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 8
- 229940079593 drug Drugs 0.000 claims description 8
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 claims description 7
- 239000008194 pharmaceutical composition Substances 0.000 claims description 7
- 125000006570 (C5-C6) heteroaryl group Chemical group 0.000 claims description 6
- 206010002383 Angina Pectoris Diseases 0.000 claims description 6
- 201000001320 Atherosclerosis Diseases 0.000 claims description 6
- 208000024172 Cardiovascular disease Diseases 0.000 claims description 6
- 206010052337 Diastolic dysfunction Diseases 0.000 claims description 6
- 206010048554 Endothelial dysfunction Diseases 0.000 claims description 6
- 208000010228 Erectile Dysfunction Diseases 0.000 claims description 6
- 208000006011 Stroke Diseases 0.000 claims description 6
- 208000007536 Thrombosis Diseases 0.000 claims description 6
- 239000000674 adrenergic antagonist Substances 0.000 claims description 6
- 208000006673 asthma Diseases 0.000 claims description 6
- 230000000747 cardiac effect Effects 0.000 claims description 6
- 208000020832 chronic kidney disease Diseases 0.000 claims description 6
- 230000007882 cirrhosis Effects 0.000 claims description 6
- 208000019425 cirrhosis of liver Diseases 0.000 claims description 6
- 230000004064 dysfunction Effects 0.000 claims description 6
- 230000008694 endothelial dysfunction Effects 0.000 claims description 6
- 201000001881 impotence Diseases 0.000 claims description 6
- 208000030603 inherited susceptibility to asthma Diseases 0.000 claims description 6
- 208000010125 myocardial infarction Diseases 0.000 claims description 6
- 229910052757 nitrogen Inorganic materials 0.000 claims description 6
- 208000002815 pulmonary hypertension Diseases 0.000 claims description 6
- 208000037803 restenosis Diseases 0.000 claims description 6
- 206010020852 Hypertonia Diseases 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 5
- 239000005541 ACE inhibitor Substances 0.000 claims description 4
- 229940123338 Aldosterone synthase inhibitor Drugs 0.000 claims description 4
- 101710129690 Angiotensin-converting enzyme inhibitor Proteins 0.000 claims description 4
- 101710086378 Bradykinin-potentiating and C-type natriuretic peptides Proteins 0.000 claims description 4
- 229940127291 Calcium channel antagonist Drugs 0.000 claims description 4
- 229940118365 Endothelin receptor antagonist Drugs 0.000 claims description 4
- 208000011514 Familial renal glucosuria Diseases 0.000 claims description 4
- 229940123333 Phosphodiesterase 5 inhibitor Drugs 0.000 claims description 4
- 206010064911 Pulmonary arterial hypertension Diseases 0.000 claims description 4
- 102000007637 Soluble Guanylyl Cyclase Human genes 0.000 claims description 4
- 108010007205 Soluble Guanylyl Cyclase Proteins 0.000 claims description 4
- 230000003213 activating effect Effects 0.000 claims description 4
- 239000013543 active substance Substances 0.000 claims description 4
- 239000002170 aldosterone antagonist Substances 0.000 claims description 4
- 229940083712 aldosterone antagonist Drugs 0.000 claims description 4
- 125000005213 alkyl heteroaryl group Chemical group 0.000 claims description 4
- 239000002333 angiotensin II receptor antagonist Substances 0.000 claims description 4
- 229940126317 angiotensin II receptor antagonist Drugs 0.000 claims description 4
- 229940044094 angiotensin-converting-enzyme inhibitor Drugs 0.000 claims description 4
- 239000002876 beta blocker Substances 0.000 claims description 4
- 239000000480 calcium channel blocker Substances 0.000 claims description 4
- 229910052799 carbon Inorganic materials 0.000 claims description 4
- 125000004432 carbon atom Chemical group C* 0.000 claims description 4
- 208000022831 chronic renal failure syndrome Diseases 0.000 claims description 4
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 4
- 239000002934 diuretic Substances 0.000 claims description 4
- 230000001882 diuretic effect Effects 0.000 claims description 4
- 239000002308 endothelin receptor antagonist Substances 0.000 claims description 4
- 239000002792 enkephalinase inhibitor Substances 0.000 claims description 4
- 125000000623 heterocyclic group Chemical group 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 230000002503 metabolic effect Effects 0.000 claims description 4
- 239000003607 modifier Substances 0.000 claims description 4
- 125000002911 monocyclic heterocycle group Chemical group 0.000 claims description 4
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 claims description 4
- 239000000810 peripheral vasodilating agent Substances 0.000 claims description 4
- 229960002116 peripheral vasodilator Drugs 0.000 claims description 4
- 239000002590 phosphodiesterase V inhibitor Substances 0.000 claims description 4
- 239000004036 potassium channel stimulating agent Substances 0.000 claims description 4
- 208000007278 renal glycosuria Diseases 0.000 claims description 4
- 239000002461 renin inhibitor Substances 0.000 claims description 4
- 229940086526 renin-inhibitors Drugs 0.000 claims description 4
- 230000002889 sympathetic effect Effects 0.000 claims description 4
- 229940124549 vasodilator Drugs 0.000 claims description 4
- 239000003071 vasodilator agent Substances 0.000 claims description 4
- 210000004072 lung Anatomy 0.000 claims description 3
- LXAOHLADQYQDKZ-UHFFFAOYSA-N 2-(8-butyl-[1,2,4]triazolo[1,5-a]pyrazin-6-yl)-5-(3,4-difluorophenyl)-5-methyl-3,7-dihydropyrrolo[2,3-d]pyrimidine-4,6-dione Chemical compound C(CCC)C=1C=2N(C=C(N=1)C=1N=C(C3=C(N=1)NC(C3(C)C1=CC(=C(C=C1)F)F)=O)O)N=CN=2 LXAOHLADQYQDKZ-UHFFFAOYSA-N 0.000 claims description 2
- DGRJGTKRMXRNLZ-UHFFFAOYSA-N 2-(8-butyl-[1,2,4]triazolo[1,5-a]pyrazin-6-yl)-5-(3-fluorophenyl)-5-methyl-3,7-dihydropyrrolo[2,3-d]pyrimidine-4,6-dione Chemical compound C(CCC)C=1C=2N(C=C(N=1)C=1N=C(C3=C(N=1)NC(C3(C)C1=CC(=CC=C1)F)=O)O)N=CN=2 DGRJGTKRMXRNLZ-UHFFFAOYSA-N 0.000 claims description 2
- MJPGVZAWISUCPN-UHFFFAOYSA-N 2-(8-butyl-[1,2,4]triazolo[1,5-a]pyrazin-6-yl)-5-(4-chloro-3-fluorophenyl)-5-methyl-3,7-dihydropyrrolo[2,3-d]pyrimidine-4,6-dione Chemical compound C(CCC)C=1C=2N(C=C(N=1)C=1N=C(C3=C(N=1)NC(C3(C)C1=CC(=C(C=C1)Cl)F)=O)O)N=CN=2 MJPGVZAWISUCPN-UHFFFAOYSA-N 0.000 claims description 2
- FQESNKDMJREXNR-UHFFFAOYSA-N 2-(8-butyl-[1,2,4]triazolo[1,5-a]pyrazin-6-yl)-5-(4-chlorophenyl)-5-methyl-3,7-dihydropyrrolo[2,3-d]pyrimidine-4,6-dione Chemical compound C(CCC)C=1C=2N(C=C(N=1)C=1N=C(C3=C(N=1)NC(C3(C)C1=CC=C(C=C1)Cl)=O)O)N=CN=2 FQESNKDMJREXNR-UHFFFAOYSA-N 0.000 claims description 2
- HQVUQJDUKZCAKM-UHFFFAOYSA-N 2-(8-butyl-[1,2,4]triazolo[1,5-a]pyrazin-6-yl)-5-(4-fluorophenyl)-5-methyl-3,7-dihydropyrrolo[2,3-d]pyrimidine-4,6-dione Chemical compound C(CCC)C=1C=2N(C=C(N=1)C=1N=C(C3=C(N=1)NC(C3(C)C1=CC=C(C=C1)F)=O)O)N=CN=2 HQVUQJDUKZCAKM-UHFFFAOYSA-N 0.000 claims description 2
- IRJDCCOPVWQZFS-UHFFFAOYSA-N 2-(8-butyl-[1,2,4]triazolo[1,5-a]pyrazin-6-yl)-5-(5-chloropyridin-2-yl)-5-methyl-3,7-dihydropyrrolo[2,3-d]pyrimidine-4,6-dione Chemical compound C(CCC)C=1C=2N(C=C(N=1)C=1N=C(C3=C(N=1)NC(C3(C)C1=NC=C(C=C1)Cl)=O)O)N=CN=2 IRJDCCOPVWQZFS-UHFFFAOYSA-N 0.000 claims description 2
- BJTDMLIJOGMFAB-UHFFFAOYSA-N 2-(8-butyl-[1,2,4]triazolo[1,5-a]pyrazin-6-yl)-5-(5-fluoropyridin-2-yl)-5-methyl-3,7-dihydropyrrolo[2,3-d]pyrimidine-4,6-dione Chemical compound C(CCC)C=1C=2N(C=C(N=1)C=1N=C(C3=C(N=1)NC(C3(C)C1=NC=C(C=C1)F)=O)O)N=CN=2 BJTDMLIJOGMFAB-UHFFFAOYSA-N 0.000 claims description 2
- TXAOYIUUKRNHIX-UHFFFAOYSA-N 2-(8-butyl-[1,2,4]triazolo[1,5-a]pyrazin-6-yl)-5-methyl-5-(5-methylpyridin-2-yl)-3,7-dihydropyrrolo[2,3-d]pyrimidine-4,6-dione Chemical compound C(CCC)C=1C=2N(C=C(N=1)C=1N=C(C3=C(N=1)NC(C3(C1=NC=C(C=C1)C)C)=O)O)N=CN=2 TXAOYIUUKRNHIX-UHFFFAOYSA-N 0.000 claims description 2
- NVAZGOBZBPOMHJ-UHFFFAOYSA-N 2-(8-butyl-[1,2,4]triazolo[1,5-a]pyrazin-6-yl)-5-methyl-5-[5-(trifluoromethyl)pyridin-2-yl]-3,7-dihydropyrrolo[2,3-d]pyrimidine-4,6-dione Chemical compound C(CCC)C=1C=2N(C=C(N=1)C=1N=C(C3=C(N=1)NC(C3(C1=NC=C(C=C1)C(F)(F)F)C)=O)O)N=CN=2 NVAZGOBZBPOMHJ-UHFFFAOYSA-N 0.000 claims description 2
- 125000004180 3-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(F)=C1[H] 0.000 claims description 2
- LMRDQTUJMDYOSF-UHFFFAOYSA-N 4-amino-2-(8-butyl-[1,2,4]triazolo[1,5-a]pyrazin-6-yl)-5-(3,4-difluorophenyl)-5-methyl-7H-pyrrolo[2,3-d]pyrimidin-6-one Chemical compound NC=1C2=C(N=C(N=1)C=1N=C(C=3N(C=1)N=CN=3)CCCC)NC(C2(C)C1=CC(=C(C=C1)F)F)=O LMRDQTUJMDYOSF-UHFFFAOYSA-N 0.000 claims description 2
- SMADCKIYUKQHTM-UHFFFAOYSA-N 4-amino-2-(8-butyl-[1,2,4]triazolo[1,5-a]pyrazin-6-yl)-5-(4-chloro-3-fluorophenyl)-5-methyl-7H-pyrrolo[2,3-d]pyrimidin-6-one Chemical compound NC=1C2=C(N=C(N=1)C=1N=C(C=3N(C=1)N=CN=3)CCCC)NC(C2(C)C1=CC(=C(C=C1)Cl)F)=O SMADCKIYUKQHTM-UHFFFAOYSA-N 0.000 claims description 2
- QKSIYKIUIRBJLO-UHFFFAOYSA-N 4-amino-2-(8-butyl-[1,2,4]triazolo[1,5-a]pyrazin-6-yl)-5-(4-chlorophenyl)-5-methyl-7H-pyrrolo[2,3-d]pyrimidin-6-one Chemical compound NC=1C2=C(N=C(N=1)C=1N=C(C=3N(C=1)N=CN=3)CCCC)NC(C2(C)C1=CC=C(C=C1)Cl)=O QKSIYKIUIRBJLO-UHFFFAOYSA-N 0.000 claims description 2
- RPLJYXSNLLLWJB-UHFFFAOYSA-N 4-amino-2-(8-butyl-[1,2,4]triazolo[1,5-a]pyrazin-6-yl)-5-(4-fluorophenyl)-5-methyl-7H-pyrrolo[2,3-d]pyrimidin-6-one Chemical compound NC=1C2=C(N=C(N=1)C=1N=C(C=3N(C=1)N=CN=3)CCCC)NC(C2(C)C1=CC=C(C=C1)F)=O RPLJYXSNLLLWJB-UHFFFAOYSA-N 0.000 claims description 2
- DKJKIOMNQFKWRU-UHFFFAOYSA-N 4-amino-2-(8-butyl-[1,2,4]triazolo[1,5-a]pyrazin-6-yl)-5-(5-chloropyridin-2-yl)-5-cyclopropyl-7H-pyrrolo[2,3-d]pyrimidin-6-one Chemical compound NC=1C2=C(N=C(N=1)C=1N=C(C=3N(C=1)N=CN=3)CCCC)NC(C2(C1CC1)C1=NC=C(C=C1)Cl)=O DKJKIOMNQFKWRU-UHFFFAOYSA-N 0.000 claims description 2
- AYDTWTCFOONFAW-UHFFFAOYSA-N 4-amino-2-(8-butyl-[1,2,4]triazolo[1,5-a]pyrazin-6-yl)-5-(5-chloropyridin-2-yl)-5-methyl-7H-pyrrolo[2,3-d]pyrimidin-6-one Chemical compound NC=1C2=C(N=C(N=1)C=1N=C(C=3N(C=1)N=CN=3)CCCC)NC(C2(C)C1=NC=C(C=C1)Cl)=O AYDTWTCFOONFAW-UHFFFAOYSA-N 0.000 claims description 2
- BYZFKKBSQNZUHA-UHFFFAOYSA-N 4-amino-2-(8-butyl-[1,2,4]triazolo[1,5-a]pyrazin-6-yl)-5-(5-fluoropyridin-2-yl)-5-methyl-7H-pyrrolo[2,3-d]pyrimidin-6-one Chemical compound NC=1C2=C(N=C(N=1)C=1N=C(C=3N(C=1)N=CN=3)CCCC)NC(C2(C)C1=NC=C(C=C1)F)=O BYZFKKBSQNZUHA-UHFFFAOYSA-N 0.000 claims description 2
- TZNMGNJFFQFDSN-UHFFFAOYSA-N 4-amino-2-(8-butyl-[1,2,4]triazolo[1,5-a]pyrazin-6-yl)-5-cyclopropyl-5-(5-methylpyridin-2-yl)-7H-pyrrolo[2,3-d]pyrimidin-6-one Chemical compound NC=1C2=C(N=C(N=1)C=1N=C(C=3N(C=1)N=CN=3)CCCC)NC(C2(C1=NC=C(C=C1)C)C1CC1)=O TZNMGNJFFQFDSN-UHFFFAOYSA-N 0.000 claims description 2
- ARPIPJLVHMRNTM-UHFFFAOYSA-N 4-amino-2-(8-butyl-[1,2,4]triazolo[1,5-a]pyrazin-6-yl)-5-cyclopropyl-5-[5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl]-7H-pyrrolo[2,3-d]pyrimidin-6-one Chemical compound NC=1C2=C(N=C(N=1)C=1N=C(C=3N(C=1)N=CN=3)CCCC)NC(C2(C=1OC(=NN=1)C(F)(F)F)C1CC1)=O ARPIPJLVHMRNTM-UHFFFAOYSA-N 0.000 claims description 2
- CFXHGGPGIWUSMF-UHFFFAOYSA-N 4-amino-2-(8-butyl-[1,2,4]triazolo[1,5-a]pyrazin-6-yl)-5-cyclopropyl-5-[5-(trifluoromethyl)pyridin-2-yl]-7H-pyrrolo[2,3-d]pyrimidin-6-one Chemical compound NC=1C2=C(N=C(N=1)C=1N=C(C=3N(C=1)N=CN=3)CCCC)NC(C2(C1=NC=C(C=C1)C(F)(F)F)C1CC1)=O CFXHGGPGIWUSMF-UHFFFAOYSA-N 0.000 claims description 2
- SQPXVCJKVFWNAT-UHFFFAOYSA-N 4-amino-2-(8-butyl-[1,2,4]triazolo[1,5-a]pyrazin-6-yl)-5-cyclopropyl-5-pyridin-2-yl-7H-pyrrolo[2,3-d]pyrimidin-6-one Chemical compound NC=1C2=C(N=C(N=1)C=1N=C(C=3N(C=1)N=CN=3)CCCC)NC(C2(C1=NC=CC=C1)C1CC1)=O SQPXVCJKVFWNAT-UHFFFAOYSA-N 0.000 claims description 2
- IBLMKKUNVUEJPK-UHFFFAOYSA-N 4-amino-2-(8-butyl-[1,2,4]triazolo[1,5-a]pyrazin-6-yl)-5-methyl-5-(5-methylpyridin-2-yl)-7H-pyrrolo[2,3-d]pyrimidin-6-one Chemical compound NC=1C2=C(N=C(N=1)C=1N=C(C=3N(C=1)N=CN=3)CCCC)NC(C2(C1=NC=C(C=C1)C)C)=O IBLMKKUNVUEJPK-UHFFFAOYSA-N 0.000 claims description 2
- WKZLLIKBYCBIRD-UHFFFAOYSA-N 4-amino-2-(8-butyl-[1,2,4]triazolo[1,5-a]pyrazin-6-yl)-5-methyl-5-[5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl]-7H-pyrrolo[2,3-d]pyrimidin-6-one Chemical compound NC=1C2=C(N=C(N=1)C=1N=C(C=3N(C=1)N=CN=3)CCCC)NC(C2(C=1OC(=NN=1)C(F)(F)F)C)=O WKZLLIKBYCBIRD-UHFFFAOYSA-N 0.000 claims description 2
- GDSOLFAUGQUSPO-UHFFFAOYSA-N 4-amino-2-(8-butyl-[1,2,4]triazolo[1,5-a]pyrazin-6-yl)-5-methyl-5-[5-(trifluoromethyl)pyridin-2-yl]-7H-pyrrolo[2,3-d]pyrimidin-6-one Chemical compound NC=1C2=C(N=C(N=1)C=1N=C(C=3N(C=1)N=CN=3)CCCC)NC(C2(C1=NC=C(C=C1)C(F)(F)F)C)=O GDSOLFAUGQUSPO-UHFFFAOYSA-N 0.000 claims description 2
- FUIAWYATXWPXHA-UHFFFAOYSA-N 4-amino-5-(3,4-difluorophenyl)-5-methyl-2-[8-(3,3,3-trifluoropropyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-7H-pyrrolo[2,3-d]pyrimidin-6-one Chemical compound NC=1C2=C(N=C(N=1)C=1N=C(C=3N(C=1)N=CN=3)CCC(F)(F)F)NC(C2(C)C1=CC(=C(C=C1)F)F)=O FUIAWYATXWPXHA-UHFFFAOYSA-N 0.000 claims description 2
- UXFLSGRTDQWADO-UHFFFAOYSA-N 4-amino-5-(3,4-difluorophenyl)-5-methyl-2-[8-(4,4,4-trifluorobutyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-7H-pyrrolo[2,3-d]pyrimidin-6-one Chemical compound NC=1C2=C(N=C(N=1)C=1N=C(C=3N(C=1)N=CN=3)CCCC(F)(F)F)NC(C2(C)C1=CC(=C(C=C1)F)F)=O UXFLSGRTDQWADO-UHFFFAOYSA-N 0.000 claims description 2
- DPINFZKMEZBXOX-UHFFFAOYSA-N 4-amino-5-(3-fluorophenyl)-5-methyl-2-[8-(3,3,4,4,4-pentafluorobutyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-7H-pyrrolo[2,3-d]pyrimidin-6-one Chemical compound NC=1C2=C(N=C(N=1)C=1N=C(C=3N(C=1)N=CN=3)CCC(C(F)(F)F)(F)F)NC(C2(C)C1=CC(=CC=C1)F)=O DPINFZKMEZBXOX-UHFFFAOYSA-N 0.000 claims description 2
- NCRWABGVHDOFSY-UHFFFAOYSA-N 4-amino-5-(4-chloro-3-fluorophenyl)-5-cyclopropyl-2-[8-(4,4,4-trifluorobutyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-7H-pyrrolo[2,3-d]pyrimidin-6-one Chemical compound NC=1C2=C(N=C(N=1)C=1N=C(C=3N(C=1)N=CN=3)CCCC(F)(F)F)NC(C2(C1CC1)C1=CC(=C(C=C1)Cl)F)=O NCRWABGVHDOFSY-UHFFFAOYSA-N 0.000 claims description 2
- ILAXOCFPUSBEAT-UHFFFAOYSA-N 4-amino-5-(4-chloro-3-fluorophenyl)-5-methyl-2-[8-(3,3,3-trifluoropropyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-7H-pyrrolo[2,3-d]pyrimidin-6-one Chemical compound NC=1C2=C(N=C(N=1)C=1N=C(C=3N(C=1)N=CN=3)CCC(F)(F)F)NC(C2(C)C1=CC(=C(C=C1)Cl)F)=O ILAXOCFPUSBEAT-UHFFFAOYSA-N 0.000 claims description 2
- JYDSMTRMKOUTQS-UHFFFAOYSA-N 4-amino-5-(4-chloro-3-fluorophenyl)-5-methyl-2-[8-(3,3,4,4,4-pentafluorobutyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-7H-pyrrolo[2,3-d]pyrimidin-6-one Chemical group NC=1C2=C(N=C(N=1)C=1N=C(C=3N(C=1)N=CN=3)CCC(C(F)(F)F)(F)F)NC(C2(C)C1=CC(=C(C=C1)Cl)F)=O JYDSMTRMKOUTQS-UHFFFAOYSA-N 0.000 claims description 2
- FQFPGEPRBPWOPZ-UHFFFAOYSA-N 4-amino-5-(4-chloro-3-fluorophenyl)-5-methyl-2-[8-(4,4,4-trifluorobutyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-7H-pyrrolo[2,3-d]pyrimidin-6-one Chemical compound NC=1C2=C(N=C(N=1)C=1N=C(C=3N(C=1)N=CN=3)CCCC(F)(F)F)NC(C2(C)C1=CC(=C(C=C1)Cl)F)=O FQFPGEPRBPWOPZ-UHFFFAOYSA-N 0.000 claims description 2
- IYELZELRRUTSRM-UHFFFAOYSA-N 4-amino-5-(4-chlorophenyl)-5-cyclopropyl-2-[8-(4,4,4-trifluorobutyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-7H-pyrrolo[2,3-d]pyrimidin-6-one Chemical compound NC=1C2=C(N=C(N=1)C=1N=C(C=3N(C=1)N=CN=3)CCCC(F)(F)F)NC(C2(C1CC1)C1=CC=C(C=C1)Cl)=O IYELZELRRUTSRM-UHFFFAOYSA-N 0.000 claims description 2
- WGIHAFPDROKWSX-UHFFFAOYSA-N 4-amino-5-(4-chlorophenyl)-5-methyl-2-(8-propyl-[1,2,4]triazolo[1,5-a]pyrazin-6-yl)-7H-pyrrolo[2,3-d]pyrimidin-6-one Chemical compound NC=1C2=C(N=C(N=1)C=1N=C(C=3N(C=1)N=CN=3)CCC)NC(C2(C)C1=CC=C(C=C1)Cl)=O WGIHAFPDROKWSX-UHFFFAOYSA-N 0.000 claims description 2
- NDUOXCAEGKOONQ-UHFFFAOYSA-N 4-amino-5-(4-chlorophenyl)-5-methyl-2-[8-(3,3,3-trifluoropropyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-7H-pyrrolo[2,3-d]pyrimidin-6-one Chemical compound NC=1C2=C(N=C(N=1)C=1N=C(C=3N(C=1)N=CN=3)CCC(F)(F)F)NC(C2(C)C1=CC=C(C=C1)Cl)=O NDUOXCAEGKOONQ-UHFFFAOYSA-N 0.000 claims description 2
- VCHOMOPTXOUEGA-UHFFFAOYSA-N 4-amino-5-(4-chlorophenyl)-5-methyl-2-[8-(3,3,4,4,4-pentafluorobutyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-7H-pyrrolo[2,3-d]pyrimidin-6-one Chemical group NC=1C2=C(N=C(N=1)C=1N=C(C=3N(C=1)N=CN=3)CCC(C(F)(F)F)(F)F)NC(C2(C)C1=CC=C(C=C1)Cl)=O VCHOMOPTXOUEGA-UHFFFAOYSA-N 0.000 claims description 2
- CRBYPVKGLITJSM-UHFFFAOYSA-N 4-amino-5-(4-chlorophenyl)-5-methyl-2-[8-(4,4,4-trifluorobutyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-7H-pyrrolo[2,3-d]pyrimidin-6-one Chemical compound NC=1C2=C(N=C(N=1)C=1N=C(C=3N(C=1)N=CN=3)CCCC(F)(F)F)NC(C2(C)C1=CC=C(C=C1)Cl)=O CRBYPVKGLITJSM-UHFFFAOYSA-N 0.000 claims description 2
- DNHSGSFOYNRUGB-UHFFFAOYSA-N 4-amino-5-(4-fluorophenyl)-2-[8-[(3-hydroxyphenyl)methyl]-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-5-methyl-7H-pyrrolo[2,3-d]pyrimidin-6-one Chemical compound NC=1C2=C(N=C(N=1)C=1N=C(C=3N(C=1)N=CN=3)CC1=CC(=CC=C1)O)NC(C2(C)C1=CC=C(C=C1)F)=O DNHSGSFOYNRUGB-UHFFFAOYSA-N 0.000 claims description 2
- DXRSOXNGZMNAEL-UHFFFAOYSA-N 4-amino-5-(4-fluorophenyl)-2-[8-[(3-methoxyphenyl)methyl]-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-5-methyl-7H-pyrrolo[2,3-d]pyrimidin-6-one Chemical compound NC=1C2=C(N=C(N=1)C=1N=C(C=3N(C=1)N=CN=3)CC1=CC(=CC=C1)OC)NC(C2(C)C1=CC=C(C=C1)F)=O DXRSOXNGZMNAEL-UHFFFAOYSA-N 0.000 claims description 2
- SVGKONLUXXYSDL-UHFFFAOYSA-N 4-amino-5-(4-fluorophenyl)-2-[8-[(4-fluorophenyl)methyl]-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-5-methyl-7H-pyrrolo[2,3-d]pyrimidin-6-one Chemical compound NC=1C2=C(N=C(N=1)C=1N=C(C=3N(C=1)N=CN=3)CC1=CC=C(C=C1)F)NC(C2(C)C1=CC=C(C=C1)F)=O SVGKONLUXXYSDL-UHFFFAOYSA-N 0.000 claims description 2
- IYYOKZKDGWDNSR-UHFFFAOYSA-N 4-amino-5-(4-fluorophenyl)-5-methyl-2-(8-propyl-[1,2,4]triazolo[1,5-a]pyrazin-6-yl)-7H-pyrrolo[2,3-d]pyrimidin-6-one Chemical compound NC=1C2=C(N=C(N=1)C=1N=C(C=3N(C=1)N=CN=3)CCC)NC(C2(C)C1=CC=C(C=C1)F)=O IYYOKZKDGWDNSR-UHFFFAOYSA-N 0.000 claims description 2
- ZVOJZWYYPZJKMF-UHFFFAOYSA-N 4-amino-5-(4-fluorophenyl)-5-methyl-2-[8-(2-methylpropyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-7H-pyrrolo[2,3-d]pyrimidin-6-one Chemical compound NC=1C2=C(N=C(N=1)C=1N=C(C=3N(C=1)N=CN=3)CC(C)C)NC(C2(C)C1=CC=C(C=C1)F)=O ZVOJZWYYPZJKMF-UHFFFAOYSA-N 0.000 claims description 2
- HUKLGQVMRPFACU-UHFFFAOYSA-N 4-amino-5-(4-fluorophenyl)-5-methyl-2-[8-(3,3,3-trifluoropropyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-7H-pyrrolo[2,3-d]pyrimidin-6-one Chemical compound NC=1C2=C(N=C(N=1)C=1N=C(C=3N(C=1)N=CN=3)CCC(F)(F)F)NC(C2(C)C1=CC=C(C=C1)F)=O HUKLGQVMRPFACU-UHFFFAOYSA-N 0.000 claims description 2
- MGCUKPRMLIXYBY-UHFFFAOYSA-N 4-amino-5-(4-fluorophenyl)-5-methyl-2-[8-(3,3,4,4,4-pentafluorobutyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-7H-pyrrolo[2,3-d]pyrimidin-6-one Chemical group NC=1C2=C(N=C(N=1)C=1N=C(C=3N(C=1)N=CN=3)CCC(C(F)(F)F)(F)F)NC(C2(C)C1=CC=C(C=C1)F)=O MGCUKPRMLIXYBY-UHFFFAOYSA-N 0.000 claims description 2
- CQLKLARDQREQRQ-UHFFFAOYSA-N 4-amino-5-(4-fluorophenyl)-5-methyl-2-[8-(4,4,4-trifluorobutyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-7H-pyrrolo[2,3-d]pyrimidin-6-one Chemical compound NC=1C2=C(N=C(N=1)C=1N=C(C=3N(C=1)N=CN=3)CCCC(F)(F)F)NC(C2(C)C1=CC=C(C=C1)F)=O CQLKLARDQREQRQ-UHFFFAOYSA-N 0.000 claims description 2
- USCPQVQKQOPVOT-UHFFFAOYSA-N 4-amino-5-(5-chloropyridin-2-yl)-5-cyclopropyl-2-(8-propyl-[1,2,4]triazolo[1,5-a]pyrazin-6-yl)-7H-pyrrolo[2,3-d]pyrimidin-6-one Chemical compound NC=1C2=C(N=C(N=1)C=1N=C(C=3N(C=1)N=CN=3)CCC)NC(C2(C1CC1)C1=NC=C(C=C1)Cl)=O USCPQVQKQOPVOT-UHFFFAOYSA-N 0.000 claims description 2
- GMEBMHXLCRVCDL-UHFFFAOYSA-N 4-amino-5-(5-chloropyridin-2-yl)-5-cyclopropyl-2-[8-(3,3,3-trifluoropropyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-7H-pyrrolo[2,3-d]pyrimidin-6-one Chemical compound NC=1C2=C(N=C(N=1)C=1N=C(C=3N(C=1)N=CN=3)CCC(F)(F)F)NC(C2(C1CC1)C1=NC=C(C=C1)Cl)=O GMEBMHXLCRVCDL-UHFFFAOYSA-N 0.000 claims description 2
- LAELRCHSNCTPJT-UHFFFAOYSA-N 4-amino-5-(5-chloropyridin-2-yl)-5-cyclopropyl-2-[8-(3,3,4,4,4-pentafluorobutyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-7H-pyrrolo[2,3-d]pyrimidin-6-one Chemical group NC=1C2=C(N=C(N=1)C=1N=C(C=3N(C=1)N=CN=3)CCC(C(F)(F)F)(F)F)NC(C2(C1CC1)C1=NC=C(C=C1)Cl)=O LAELRCHSNCTPJT-UHFFFAOYSA-N 0.000 claims description 2
- HLXPYMUSAFZNAF-UHFFFAOYSA-N 4-amino-5-(5-chloropyridin-2-yl)-5-cyclopropyl-2-[8-(4,4,4-trifluorobutyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-7H-pyrrolo[2,3-d]pyrimidin-6-one Chemical compound NC=1C2=C(N=C(N=1)C=1N=C(C=3N(C=1)N=CN=3)CCCC(F)(F)F)NC(C2(C1CC1)C1=NC=C(C=C1)Cl)=O HLXPYMUSAFZNAF-UHFFFAOYSA-N 0.000 claims description 2
- MZIXUNMCTVYUOH-UHFFFAOYSA-N 4-amino-5-(5-chloropyridin-2-yl)-5-methyl-2-[8-(3,3,3-trifluoropropyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-7H-pyrrolo[2,3-d]pyrimidin-6-one Chemical compound NC=1C2=C(N=C(N=1)C=1N=C(C=3N(C=1)N=CN=3)CCC(F)(F)F)NC(C2(C)C1=NC=C(C=C1)Cl)=O MZIXUNMCTVYUOH-UHFFFAOYSA-N 0.000 claims description 2
- TWEAKVSWDSWQBJ-UHFFFAOYSA-N 4-amino-5-(5-chloropyridin-2-yl)-5-methyl-2-[8-(3,3,4,4,4-pentafluorobutyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-7H-pyrrolo[2,3-d]pyrimidin-6-one Chemical group NC=1C2=C(N=C(N=1)C=1N=C(C=3N(C=1)N=CN=3)CCC(C(F)(F)F)(F)F)NC(C2(C)C1=NC=C(C=C1)Cl)=O TWEAKVSWDSWQBJ-UHFFFAOYSA-N 0.000 claims description 2
- XMYVQHFFWOGGMA-UHFFFAOYSA-N 4-amino-5-(5-chloropyridin-2-yl)-5-methyl-2-[8-(4,4,4-trifluorobutyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-7H-pyrrolo[2,3-d]pyrimidin-6-one Chemical compound NC=1C2=C(N=C(N=1)C=1N=C(C=3N(C=1)N=CN=3)CCCC(F)(F)F)NC(C2(C)C1=NC=C(C=C1)Cl)=O XMYVQHFFWOGGMA-UHFFFAOYSA-N 0.000 claims description 2
- PLDWBQCIJIWSGW-UHFFFAOYSA-N 4-amino-5-(5-chloropyrimidin-2-yl)-5-cyclopropyl-2-[8-(4,4,4-trifluorobutyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-7H-pyrrolo[2,3-d]pyrimidin-6-one Chemical compound NC=1C2=C(N=C(N=1)C=1N=C(C=3N(C=1)N=CN=3)CCCC(F)(F)F)NC(C2(C1CC1)C1=NC=C(C=N1)Cl)=O PLDWBQCIJIWSGW-UHFFFAOYSA-N 0.000 claims description 2
- RORZLIFFXJHOTM-UHFFFAOYSA-N 4-amino-5-(5-cyclopropyl-1,3,4-oxadiazol-2-yl)-5-methyl-2-[8-(4,4,4-trifluorobutyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-7H-pyrrolo[2,3-d]pyrimidin-6-one Chemical compound NC=1C2=C(N=C(N=1)C=1N=C(C=3N(C=1)N=CN=3)CCCC(F)(F)F)NC(C2(C)C=1OC(=NN=1)C1CC1)=O RORZLIFFXJHOTM-UHFFFAOYSA-N 0.000 claims description 2
- ZTRBJGVTFSWFHO-UHFFFAOYSA-N 4-amino-5-(5-fluoropyridin-2-yl)-5-methyl-2-(8-propyl-[1,2,4]triazolo[1,5-a]pyrazin-6-yl)-7H-pyrrolo[2,3-d]pyrimidin-6-one Chemical compound NC=1C2=C(N=C(N=1)C=1N=C(C=3N(C=1)N=CN=3)CCC)NC(C2(C)C1=NC=C(C=C1)F)=O ZTRBJGVTFSWFHO-UHFFFAOYSA-N 0.000 claims description 2
- KWOUQRODWWUDFA-UHFFFAOYSA-N 4-amino-5-(5-fluoropyridin-2-yl)-5-methyl-2-[8-(3,3,3-trifluoropropyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-7H-pyrrolo[2,3-d]pyrimidin-6-one Chemical compound NC=1C2=C(N=C(N=1)C=1N=C(C=3N(C=1)N=CN=3)CCC(F)(F)F)NC(C2(C)C1=NC=C(C=C1)F)=O KWOUQRODWWUDFA-UHFFFAOYSA-N 0.000 claims description 2
- VAEQWDRGIKNKKS-UHFFFAOYSA-N 4-amino-5-(5-fluoropyridin-2-yl)-5-methyl-2-[8-(3,3,4,4,4-pentafluorobutyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-7H-pyrrolo[2,3-d]pyrimidin-6-one Chemical group NC=1C2=C(N=C(N=1)C=1N=C(C=3N(C=1)N=CN=3)CCC(C(F)(F)F)(F)F)NC(C2(C)C1=NC=C(C=C1)F)=O VAEQWDRGIKNKKS-UHFFFAOYSA-N 0.000 claims description 2
- VWQLPDQCMBHHSS-UHFFFAOYSA-N 4-amino-5-(5-fluoropyridin-2-yl)-5-methyl-2-[8-(4,4,4-trifluorobutyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-7H-pyrrolo[2,3-d]pyrimidin-6-one Chemical compound NC=1C2=C(N=C(N=1)C=1N=C(C=3N(C=1)N=CN=3)CCCC(F)(F)F)NC(C2(C)C1=NC=C(C=C1)F)=O VWQLPDQCMBHHSS-UHFFFAOYSA-N 0.000 claims description 2
- SHFRQEFCNIPPLT-UHFFFAOYSA-N 4-amino-5-(5-fluoropyridin-3-yl)-5-methyl-2-[8-(3,3,4,4,4-pentafluorobutyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-7H-pyrrolo[2,3-d]pyrimidin-6-one Chemical group NC=1C2=C(N=C(N=1)C=1N=C(C=3N(C=1)N=CN=3)CCC(C(F)(F)F)(F)F)NC(C2(C)C=1C=NC=C(C=1)F)=O SHFRQEFCNIPPLT-UHFFFAOYSA-N 0.000 claims description 2
- IFJCGHBLZJDHAR-UHFFFAOYSA-N 4-amino-5-(5-hydroxypyridin-2-yl)-5-methyl-2-[8-(3,3,4,4,4-pentafluorobutyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-7H-pyrrolo[2,3-d]pyrimidin-6-one Chemical compound NC=1C2=C(N=C(N=1)C=1N=C(C=3N(C=1)N=CN=3)CCC(C(F)(F)F)(F)F)NC(C2(C)C1=NC=C(C=C1)O)=O IFJCGHBLZJDHAR-UHFFFAOYSA-N 0.000 claims description 2
- BHSFYGHVINOUOL-UHFFFAOYSA-N 4-amino-5-(5-hydroxypyridin-2-yl)-5-methyl-2-[8-(4,4,4-trifluorobutyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-7H-pyrrolo[2,3-d]pyrimidin-6-one Chemical compound NC=1C2=C(N=C(N=1)C=1N=C(C=3N(C=1)N=CN=3)CCCC(F)(F)F)NC(C2(C)C1=NC=C(C=C1)O)=O BHSFYGHVINOUOL-UHFFFAOYSA-N 0.000 claims description 2
- ZEYPXJBGPKEDQQ-UHFFFAOYSA-N 4-amino-5-(5-methoxypyridin-2-yl)-5-methyl-2-[8-(4,4,4-trifluorobutyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-7H-pyrrolo[2,3-d]pyrimidin-6-one Chemical compound NC=1C2=C(N=C(N=1)C=1N=C(C=3N(C=1)N=CN=3)CCCC(F)(F)F)NC(C2(C)C1=NC=C(C=C1)OC)=O ZEYPXJBGPKEDQQ-UHFFFAOYSA-N 0.000 claims description 2
- RVMPPSLJQUDFMZ-UHFFFAOYSA-N 4-amino-5-(6-cyclopropylpyridin-3-yl)-5-methyl-2-[8-(3,3,4,4,4-pentafluorobutyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-7H-pyrrolo[2,3-d]pyrimidin-6-one Chemical compound NC=1C2=C(N=C(N=1)C=1N=C(C=3N(C=1)N=CN=3)CCC(C(F)(F)F)(F)F)NC(C2(C)C=1C=NC(=CC=1)C1CC1)=O RVMPPSLJQUDFMZ-UHFFFAOYSA-N 0.000 claims description 2
- DGEWSXUGPVTVRX-UHFFFAOYSA-N 4-amino-5-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-5-methyl-2-[8-(4,4,4-trifluorobutyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-7H-pyrrolo[2,3-d]pyrimidin-6-one Chemical compound NC=1C2=C(N=C(N=1)C=1N=C(C=3N(C=1)N=CN=3)CCCC(F)(F)F)NC(C2(C)C=1OC(=NN=1)C(F)F)=O DGEWSXUGPVTVRX-UHFFFAOYSA-N 0.000 claims description 2
- VJIXNODGCBZXAZ-UHFFFAOYSA-N 4-amino-5-[6-(1,1-difluoroethyl)pyridin-3-yl]-5-methyl-2-[8-(3,3,4,4,4-pentafluorobutyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-7H-pyrrolo[2,3-d]pyrimidin-6-one Chemical compound NC=1C2=C(N=C(N=1)C=1N=C(C=3N(C=1)N=CN=3)CCC(C(F)(F)F)(F)F)NC(C2(C)C=1C=NC(=CC=1)C(C)(F)F)=O VJIXNODGCBZXAZ-UHFFFAOYSA-N 0.000 claims description 2
- SGDXPIZSAOAEGS-UHFFFAOYSA-N 4-amino-5-[6-(1,1-difluoroethyl)pyridin-3-yl]-5-methyl-2-[8-(4,4,4-trifluorobutyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-7H-pyrrolo[2,3-d]pyrimidin-6-one Chemical compound NC=1C2=C(N=C(N=1)C=1N=C(C=3N(C=1)N=CN=3)CCCC(F)(F)F)NC(C2(C)C=1C=NC(=CC=1)C(C)(F)F)=O SGDXPIZSAOAEGS-UHFFFAOYSA-N 0.000 claims description 2
- UDKBGNHZFUMFSW-UHFFFAOYSA-N 4-amino-5-cyclopropyl-2-(8-propyl-[1,2,4]triazolo[1,5-a]pyrazin-6-yl)-5-[5-(trifluoromethyl)pyridin-2-yl]-7H-pyrrolo[2,3-d]pyrimidin-6-one Chemical compound NC=1C2=C(N=C(N=1)C=1N=C(C=3N(C=1)N=CN=3)CCC)NC(C2(C1=NC=C(C=C1)C(F)(F)F)C1CC1)=O UDKBGNHZFUMFSW-UHFFFAOYSA-N 0.000 claims description 2
- DWPKLHAHQVIOGN-UHFFFAOYSA-N 4-amino-5-cyclopropyl-2-[8-(3,3,4,4,4-pentafluorobutyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-5-[5-(trifluoromethyl)pyridin-2-yl]-7H-pyrrolo[2,3-d]pyrimidin-6-one Chemical compound NC=1C2=C(N=C(N=1)C=1N=C(C=3N(C=1)N=CN=3)CCC(C(F)(F)F)(F)F)NC(C2(C1=NC=C(C=C1)C(F)(F)F)C1CC1)=O DWPKLHAHQVIOGN-UHFFFAOYSA-N 0.000 claims description 2
- LBYFGSUCUDWNPM-UHFFFAOYSA-N 4-amino-5-cyclopropyl-2-[8-(3,3,4,4,4-pentafluorobutyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-5-pyridin-2-yl-7H-pyrrolo[2,3-d]pyrimidin-6-one Chemical compound NC=1C2=C(N=C(N=1)C=1N=C(C=3N(C=1)N=CN=3)CCC(C(F)(F)F)(F)F)NC(C2(C1=NC=CC=C1)C1CC1)=O LBYFGSUCUDWNPM-UHFFFAOYSA-N 0.000 claims description 2
- STJVSZIVMJVSAU-UHFFFAOYSA-N 4-amino-5-cyclopropyl-2-[8-(4,4,4-trifluorobutyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-5-[4-(trifluoromethyl)phenyl]-7H-pyrrolo[2,3-d]pyrimidin-6-one Chemical compound NC=1C2=C(N=C(N=1)C=1N=C(C=3N(C=1)N=CN=3)CCCC(F)(F)F)NC(C2(C1=CC=C(C=C1)C(F)(F)F)C1CC1)=O STJVSZIVMJVSAU-UHFFFAOYSA-N 0.000 claims description 2
- HLNJUOKYJJEMME-UHFFFAOYSA-N 4-amino-5-cyclopropyl-2-[8-(4,4,4-trifluorobutyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-5-[5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl]-7H-pyrrolo[2,3-d]pyrimidin-6-one Chemical compound NC=1C2=C(N=C(N=1)C=1N=C(C=3N(C=1)N=CN=3)CCCC(F)(F)F)NC(C2(C=1OC(=NN=1)C(F)(F)F)C1CC1)=O HLNJUOKYJJEMME-UHFFFAOYSA-N 0.000 claims description 2
- XMRXUIDAWODQQT-UHFFFAOYSA-N 4-amino-5-cyclopropyl-2-[8-(4,4,4-trifluorobutyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-5-[5-(trifluoromethyl)pyridin-2-yl]-7H-pyrrolo[2,3-d]pyrimidin-6-one Chemical group NC=1C2=C(N=C(N=1)C=1N=C(C=3N(C=1)N=CN=3)CCCC(F)(F)F)NC(C2(C1=NC=C(C=C1)C(F)(F)F)C1CC1)=O XMRXUIDAWODQQT-UHFFFAOYSA-N 0.000 claims description 2
- NXTJAESHJIRCED-UHFFFAOYSA-N 4-amino-5-cyclopropyl-2-[8-(4,4,4-trifluorobutyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-5-[5-(trifluoromethyl)pyrimidin-2-yl]-7H-pyrrolo[2,3-d]pyrimidin-6-one Chemical compound NC=1C2=C(N=C(N=1)C=1N=C(C=3N(C=1)N=CN=3)CCCC(F)(F)F)NC(C2(C1=NC=C(C=N1)C(F)(F)F)C1CC1)=O NXTJAESHJIRCED-UHFFFAOYSA-N 0.000 claims description 2
- CAIUNFCQTGOBEW-UHFFFAOYSA-N 4-amino-5-cyclopropyl-5-(1-cyclopropyltriazol-4-yl)-2-[8-(3,3,4,4,4-pentafluorobutyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-7H-pyrrolo[2,3-d]pyrimidin-6-one Chemical compound NC=1C2=C(N=C(N=1)C=1N=C(C=3N(C=1)N=CN=3)CCC(C(F)(F)F)(F)F)NC(C2(C=1N=NN(C=1)C1CC1)C1CC1)=O CAIUNFCQTGOBEW-UHFFFAOYSA-N 0.000 claims description 2
- CKTKGBXOLMFEIA-UHFFFAOYSA-N 4-amino-5-cyclopropyl-5-(3,4-difluorophenyl)-2-(8-propyl-[1,2,4]triazolo[1,5-a]pyrazin-6-yl)-7H-pyrrolo[2,3-d]pyrimidin-6-one Chemical compound NC=1C2=C(N=C(N=1)C=1N=C(C=3N(C=1)N=CN=3)CCC)NC(C2(C1=CC(=C(C=C1)F)F)C1CC1)=O CKTKGBXOLMFEIA-UHFFFAOYSA-N 0.000 claims description 2
- AKCBHEFDOWJMBE-UHFFFAOYSA-N 4-amino-5-cyclopropyl-5-(3,4-difluorophenyl)-2-[8-(3,3,3-trifluoropropyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-7H-pyrrolo[2,3-d]pyrimidin-6-one Chemical compound NC=1C2=C(N=C(N=1)C=1N=C(C=3N(C=1)N=CN=3)CCC(F)(F)F)NC(C2(C1=CC(=C(C=C1)F)F)C1CC1)=O AKCBHEFDOWJMBE-UHFFFAOYSA-N 0.000 claims description 2
- OBPMXGOBTRMOQX-UHFFFAOYSA-N 4-amino-5-cyclopropyl-5-(3,4-difluorophenyl)-2-[8-(3,3,4,4,4-pentafluorobutyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-7H-pyrrolo[2,3-d]pyrimidin-6-one Chemical group NC=1C2=C(N=C(N=1)C=1N=C(C=3N(C=1)N=CN=3)CCC(C(F)(F)F)(F)F)NC(C2(C1=CC(=C(C=C1)F)F)C1CC1)=O OBPMXGOBTRMOQX-UHFFFAOYSA-N 0.000 claims description 2
- VAPMPFHTGOYTKX-UHFFFAOYSA-N 4-amino-5-cyclopropyl-5-(3,4-difluorophenyl)-2-[8-(4,4,4-trifluorobutyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-7H-pyrrolo[2,3-d]pyrimidin-6-one Chemical compound NC=1C2=C(N=C(N=1)C=1N=C(C=3N(C=1)N=CN=3)CCCC(F)(F)F)NC(C2(C1=CC(=C(C=C1)F)F)C1CC1)=O VAPMPFHTGOYTKX-UHFFFAOYSA-N 0.000 claims description 2
- HLRUZIKEMSSUDD-UHFFFAOYSA-N 4-amino-5-cyclopropyl-5-(4-fluorophenyl)-2-[8-(4,4,4-trifluorobutyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-7H-pyrrolo[2,3-d]pyrimidin-6-one Chemical compound NC=1C2=C(N=C(N=1)C=1N=C(C=3N(C=1)N=CN=3)CCCC(F)(F)F)NC(C2(C1=CC=C(C=C1)F)C1CC1)=O HLRUZIKEMSSUDD-UHFFFAOYSA-N 0.000 claims description 2
- GVMVMZLPQNTYFX-UHFFFAOYSA-N 4-amino-5-cyclopropyl-5-(5-cyclopropyl-1,3,4-oxadiazol-2-yl)-2-[8-(3,3,4,4,4-pentafluorobutyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-7H-pyrrolo[2,3-d]pyrimidin-6-one Chemical compound NC=1C2=C(N=C(N=1)C=1N=C(C=3N(C=1)N=CN=3)CCC(C(F)(F)F)(F)F)NC(C2(C=1OC(=NN=1)C1CC1)C1CC1)=O GVMVMZLPQNTYFX-UHFFFAOYSA-N 0.000 claims description 2
- NNCUDLVFZBWIPD-UHFFFAOYSA-N 4-amino-5-cyclopropyl-5-(5-cyclopropyl-1,3,4-oxadiazol-2-yl)-2-[8-(4,4,4-trifluorobutyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-7H-pyrrolo[2,3-d]pyrimidin-6-one Chemical compound NC=1C2=C(N=C(N=1)C=1N=C(C=3N(C=1)N=CN=3)CCCC(F)(F)F)NC(C2(C=1OC(=NN=1)C1CC1)C1CC1)=O NNCUDLVFZBWIPD-UHFFFAOYSA-N 0.000 claims description 2
- YWGLIMUDDCYNLB-UHFFFAOYSA-N 4-amino-5-cyclopropyl-5-(5-fluoropyridin-2-yl)-2-(8-propyl-[1,2,4]triazolo[1,5-a]pyrazin-6-yl)-7H-pyrrolo[2,3-d]pyrimidin-6-one Chemical compound NC=1C2=C(N=C(N=1)C=1N=C(C=3N(C=1)N=CN=3)CCC)NC(C2(C1=NC=C(C=C1)F)C1CC1)=O YWGLIMUDDCYNLB-UHFFFAOYSA-N 0.000 claims description 2
- FWEBZICMYGMECR-UHFFFAOYSA-N 4-amino-5-cyclopropyl-5-(5-fluoropyridin-2-yl)-2-[8-(4,4,4-trifluorobutyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-7H-pyrrolo[2,3-d]pyrimidin-6-one Chemical compound NC=1C2=C(N=C(N=1)C=1N=C(C=3N(C=1)N=CN=3)CCCC(F)(F)F)NC(C2(C1=NC=C(C=C1)F)C1CC1)=O FWEBZICMYGMECR-UHFFFAOYSA-N 0.000 claims description 2
- PGTGKLBIWILVAP-UHFFFAOYSA-N 4-amino-5-cyclopropyl-5-(5-fluoropyridin-3-yl)-2-[8-(3,3,4,4,4-pentafluorobutyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-7H-pyrrolo[2,3-d]pyrimidin-6-one Chemical group NC=1C2=C(N=C(N=1)C=1N=C(C=3N(C=1)N=CN=3)CCC(C(F)(F)F)(F)F)NC(C2(C=1C=NC=C(C=1)F)C1CC1)=O PGTGKLBIWILVAP-UHFFFAOYSA-N 0.000 claims description 2
- CKEYVUUKZGJNEV-UHFFFAOYSA-N 4-amino-5-cyclopropyl-5-(5-hydroxypyridin-2-yl)-2-[8-(4,4,4-trifluorobutyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-7H-pyrrolo[2,3-d]pyrimidin-6-one Chemical compound NC=1C2=C(N=C(N=1)C=1N=C(C=3N(C=1)N=CN=3)CCCC(F)(F)F)NC(C2(C1=NC=C(C=C1)O)C1CC1)=O CKEYVUUKZGJNEV-UHFFFAOYSA-N 0.000 claims description 2
- AVMSVDHMKIFGKX-UHFFFAOYSA-N 4-amino-5-cyclopropyl-5-(5-methoxypyridin-2-yl)-2-[8-(4,4,4-trifluorobutyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-7H-pyrrolo[2,3-d]pyrimidin-6-one Chemical compound NC=1C2=C(N=C(N=1)C=1N=C(C=3N(C=1)N=CN=3)CCCC(F)(F)F)NC(C2(C1=NC=C(C=C1)OC)C1CC1)=O AVMSVDHMKIFGKX-UHFFFAOYSA-N 0.000 claims description 2
- YCSHDNZHOLZUCA-UHFFFAOYSA-N 4-amino-5-cyclopropyl-5-(5-methylpyridin-2-yl)-2-[8-(3,3,4,4,4-pentafluorobutyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-7H-pyrrolo[2,3-d]pyrimidin-6-one Chemical compound NC=1C2=C(N=C(N=1)C=1N=C(C=3N(C=1)N=CN=3)CCC(C(F)(F)F)(F)F)NC(C2(C1=NC=C(C=C1)C)C1CC1)=O YCSHDNZHOLZUCA-UHFFFAOYSA-N 0.000 claims description 2
- JBCFREOWAKXADE-UHFFFAOYSA-N 4-amino-5-cyclopropyl-5-(5-methylpyridin-2-yl)-2-[8-(4,4,4-trifluorobutyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-7H-pyrrolo[2,3-d]pyrimidin-6-one Chemical compound NC=1C2=C(N=C(N=1)C=1N=C(C=3N(C=1)N=CN=3)CCCC(F)(F)F)NC(C2(C1=NC=C(C=C1)C)C1CC1)=O JBCFREOWAKXADE-UHFFFAOYSA-N 0.000 claims description 2
- CCSJDJFJESBSTJ-UHFFFAOYSA-N 4-amino-5-cyclopropyl-5-[5-(difluoromethyl)pyridin-2-yl]-2-[8-(4,4,4-trifluorobutyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-7H-pyrrolo[2,3-d]pyrimidin-6-one Chemical compound NC=1C2=C(N=C(N=1)C=1N=C(C=3N(C=1)N=CN=3)CCCC(F)(F)F)NC(C2(C1=NC=C(C=C1)C(F)F)C1CC1)=O CCSJDJFJESBSTJ-UHFFFAOYSA-N 0.000 claims description 2
- VVDQPSLLNVAGFQ-UHFFFAOYSA-N 4-amino-5-cyclopropyl-5-[5-(trifluoromethyl)pyridin-2-yl]-2-[8-(3,3,3-trifluoropropyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-7H-pyrrolo[2,3-d]pyrimidin-6-one Chemical compound NC=1C2=C(N=C(N=1)C=1N=C(C=3N(C=1)N=CN=3)CCC(F)(F)F)NC(C2(C1=NC=C(C=C1)C(F)(F)F)C1CC1)=O VVDQPSLLNVAGFQ-UHFFFAOYSA-N 0.000 claims description 2
- MSBVNXUXJJQPIP-UHFFFAOYSA-N 4-amino-5-cyclopropyl-5-pyridin-2-yl-2-[8-(4,4,4-trifluorobutyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-7H-pyrrolo[2,3-d]pyrimidin-6-one Chemical compound NC=1C2=C(N=C(N=1)C=1N=C(C=3N(C=1)N=CN=3)CCCC(F)(F)F)NC(C2(C1=NC=CC=C1)C1CC1)=O MSBVNXUXJJQPIP-UHFFFAOYSA-N 0.000 claims description 2
- LXMPXFGBGZDHMP-UHFFFAOYSA-N 4-amino-5-methyl-2-[8-(3,3,4,4,4-pentafluorobutyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-5-(1-propan-2-yltriazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-6-one Chemical compound NC=1C2=C(N=C(N=1)C=1N=C(C=3N(C=1)N=CN=3)CCC(C(F)(F)F)(F)F)NC(C2(C)C=1N=NN(C=1)C(C)C)=O LXMPXFGBGZDHMP-UHFFFAOYSA-N 0.000 claims description 2
- VLYGQEBBZHYBMS-UHFFFAOYSA-N 4-amino-5-methyl-2-[8-(3,3,4,4,4-pentafluorobutyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-5-phenyl-7H-pyrrolo[2,3-d]pyrimidin-6-one Chemical compound NC=1C2=C(N=C(N=1)C=1N=C(C=3N(C=1)N=CN=3)CCC(C(F)(F)F)(F)F)NC(C2(C1=CC=CC=C1)C)=O VLYGQEBBZHYBMS-UHFFFAOYSA-N 0.000 claims description 2
- WJVBISFJDFEURV-UHFFFAOYSA-N 4-amino-5-methyl-2-[8-(3,3,4,4,4-pentafluorobutyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-5-pyridin-2-yl-7H-pyrrolo[2,3-d]pyrimidin-6-one Chemical group NC=1C2=C(N=C(N=1)C=1N=C(C=3N(C=1)N=CN=3)CCC(C(F)(F)F)(F)F)NC(C2(C1=NC=CC=C1)C)=O WJVBISFJDFEURV-UHFFFAOYSA-N 0.000 claims description 2
- JALDDVDOPHQSGH-UHFFFAOYSA-N 4-amino-5-methyl-2-[8-(4,4,4-trifluorobutyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-5-[4-(trifluoromethyl)phenyl]-7H-pyrrolo[2,3-d]pyrimidin-6-one Chemical compound NC=1C2=C(N=C(N=1)C=1N=C(C=3N(C=1)N=CN=3)CCCC(F)(F)F)NC(C2(C1=CC=C(C=C1)C(F)(F)F)C)=O JALDDVDOPHQSGH-UHFFFAOYSA-N 0.000 claims description 2
- WEDFAJGOXJKPEJ-UHFFFAOYSA-N 4-amino-5-methyl-2-[8-(4,4,4-trifluorobutyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-5-[5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl]-7H-pyrrolo[2,3-d]pyrimidin-6-one Chemical compound NC=1C2=C(N=C(N=1)C=1N=C(C=3N(C=1)N=CN=3)CCCC(F)(F)F)NC(C2(C=1OC(=NN=1)C(F)(F)F)C)=O WEDFAJGOXJKPEJ-UHFFFAOYSA-N 0.000 claims description 2
- VGILGXVLAPAJGV-UHFFFAOYSA-N 4-amino-5-methyl-2-[8-(4,4,4-trifluorobutyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-5-[5-(trifluoromethyl)pyrazin-2-yl]-7H-pyrrolo[2,3-d]pyrimidin-6-one Chemical compound NC=1C2=C(N=C(N=1)C=1N=C(C=3N(C=1)N=CN=3)CCCC(F)(F)F)NC(C2(C1=NC=C(N=C1)C(F)(F)F)C)=O VGILGXVLAPAJGV-UHFFFAOYSA-N 0.000 claims description 2
- ZHHHROQVQDTTFE-UHFFFAOYSA-N 4-amino-5-methyl-2-[8-(4,4,4-trifluorobutyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-5-[5-(trifluoromethyl)pyridin-2-yl]-7H-pyrrolo[2,3-d]pyrimidin-6-one Chemical compound NC=1C2=C(N=C(N=1)C=1N=C(C=3N(C=1)N=CN=3)CCCC(F)(F)F)NC(C2(C1=NC=C(C=C1)C(F)(F)F)C)=O ZHHHROQVQDTTFE-UHFFFAOYSA-N 0.000 claims description 2
- FAOZTINVUCJCHW-UHFFFAOYSA-N 4-amino-5-methyl-2-[8-(4,4,4-trifluorobutyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-5-[5-(trifluoromethyl)pyrimidin-2-yl]-7H-pyrrolo[2,3-d]pyrimidin-6-one Chemical compound NC=1C2=C(N=C(N=1)C=1N=C(C=3N(C=1)N=CN=3)CCCC(F)(F)F)NC(C2(C1=NC=C(C=N1)C(F)(F)F)C)=O FAOZTINVUCJCHW-UHFFFAOYSA-N 0.000 claims description 2
- MCJFAXLHHDSEHB-UHFFFAOYSA-N 4-amino-5-methyl-5-(5-methyl-1,3,4-oxadiazol-2-yl)-2-[8-(3,3,4,4,4-pentafluorobutyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-7H-pyrrolo[2,3-d]pyrimidin-6-one Chemical compound NC=1C2=C(N=C(N=1)C=1N=C(C=3N(C=1)N=CN=3)CCC(C(F)(F)F)(F)F)NC(C2(C=1OC(=NN=1)C)C)=O MCJFAXLHHDSEHB-UHFFFAOYSA-N 0.000 claims description 2
- XIKMBSYHZAJKPJ-UHFFFAOYSA-N 4-amino-5-methyl-5-(5-methylpyridin-2-yl)-2-[8-(3,3,4,4,4-pentafluorobutyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-7H-pyrrolo[2,3-d]pyrimidin-6-one Chemical compound NC=1C2=C(N=C(N=1)C=1N=C(C=3N(C=1)N=CN=3)CCC(C(F)(F)F)(F)F)NC(C2(C1=NC=C(C=C1)C)C)=O XIKMBSYHZAJKPJ-UHFFFAOYSA-N 0.000 claims description 2
- YGSCFPDMHZVONW-UHFFFAOYSA-N 4-amino-5-methyl-5-(5-methylpyridin-2-yl)-2-[8-(4,4,4-trifluorobutyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-7H-pyrrolo[2,3-d]pyrimidin-6-one Chemical compound NC=1C2=C(N=C(N=1)C=1N=C(C=3N(C=1)N=CN=3)CCCC(F)(F)F)NC(C2(C1=NC=C(C=C1)C)C)=O YGSCFPDMHZVONW-UHFFFAOYSA-N 0.000 claims description 2
- ACPMVAXNGRTZLY-UHFFFAOYSA-N 4-amino-5-methyl-5-[4-(trifluoromethyl)phenyl]-2-[8-(3,3,3-trifluoropropyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-7H-pyrrolo[2,3-d]pyrimidin-6-one Chemical compound NC=1C2=C(N=C(N=1)C=1N=C(C=3N(C=1)N=CN=3)CCC(F)(F)F)NC(C2(C1=CC=C(C=C1)C(F)(F)F)C)=O ACPMVAXNGRTZLY-UHFFFAOYSA-N 0.000 claims description 2
- MNDMDZWBVHYYCC-UHFFFAOYSA-N 4-amino-5-methyl-5-[5-(trifluoromethyl)pyridin-2-yl]-2-[8-(3,3,3-trifluoropropyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-7H-pyrrolo[2,3-d]pyrimidin-6-one Chemical compound NC=1C2=C(N=C(N=1)C=1N=C(C=3N(C=1)N=CN=3)CCC(F)(F)F)NC(C2(C1=NC=C(C=C1)C(F)(F)F)C)=O MNDMDZWBVHYYCC-UHFFFAOYSA-N 0.000 claims description 2
- PXLIOHPCMQJXTA-UHFFFAOYSA-N 4-amino-5-methyl-5-[6-methyl-5-(trifluoromethyl)pyridin-2-yl]-2-[8-(4,4,4-trifluorobutyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-7H-pyrrolo[2,3-d]pyrimidin-6-one Chemical compound NC=1C2=C(N=C(N=1)C=1N=C(C=3N(C=1)N=CN=3)CCCC(F)(F)F)NC(C2(C1=NC(=C(C=C1)C(F)(F)F)C)C)=O PXLIOHPCMQJXTA-UHFFFAOYSA-N 0.000 claims description 2
- WKDGLWSBKZRFFL-UHFFFAOYSA-N 4-amino-5-methyl-5-phenyl-2-[8-(4,4,4-trifluorobutyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-7H-pyrrolo[2,3-d]pyrimidin-6-one Chemical compound NC=1C2=C(N=C(N=1)C=1N=C(C=3N(C=1)N=CN=3)CCCC(F)(F)F)NC(C2(C1=CC=CC=C1)C)=O WKDGLWSBKZRFFL-UHFFFAOYSA-N 0.000 claims description 2
- VDZIFQUIIMCOSF-UHFFFAOYSA-N 4-amino-5-methyl-5-pyridin-2-yl-2-[8-(4,4,4-trifluorobutyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-7H-pyrrolo[2,3-d]pyrimidin-6-one Chemical compound NC=1C2=C(N=C(N=1)C=1N=C(C=3N(C=1)N=CN=3)CCCC(F)(F)F)NC(C2(C1=NC=CC=C1)C)=O VDZIFQUIIMCOSF-UHFFFAOYSA-N 0.000 claims description 2
- GWKFVOOOQUZTLX-UHFFFAOYSA-N 5-(2-fluorophenyl)-5-methyl-2-[8-(3,3,4,4,4-pentafluorobutyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-3,7-dihydropyrrolo[2,3-d]pyrimidine-4,6-dione Chemical compound FC1=C(C=CC=C1)C1(C(NC=2N=C(N=C(C=21)O)C=1N=C(C=2N(C=1)N=CN=2)CCC(C(F)(F)F)(F)F)=O)C GWKFVOOOQUZTLX-UHFFFAOYSA-N 0.000 claims description 2
- FXMFNQXAHCFMFN-UHFFFAOYSA-N 5-(3,4-difluorophenyl)-5-methyl-2-[8-(3,3,4,4,4-pentafluorobutyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-3,7-dihydropyrrolo[2,3-d]pyrimidine-4,6-dione Chemical compound FC=1C=C(C=CC=1F)C1(C(NC=2N=C(N=C(C=21)O)C=1N=C(C=2N(C=1)N=CN=2)CCC(C(F)(F)F)(F)F)=O)C FXMFNQXAHCFMFN-UHFFFAOYSA-N 0.000 claims description 2
- QEMBQQYXGMHHDZ-UHFFFAOYSA-N 5-(3,4-difluorophenyl)-5-methyl-2-[8-(4,4,4-trifluorobutyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-3,7-dihydropyrrolo[2,3-d]pyrimidine-4,6-dione Chemical compound FC=1C=C(C=CC=1F)C1(C(NC=2N=C(N=C(C=21)O)C=1N=C(C=2N(C=1)N=CN=2)CCCC(F)(F)F)=O)C QEMBQQYXGMHHDZ-UHFFFAOYSA-N 0.000 claims description 2
- UYOVMYULXQMQPB-UHFFFAOYSA-N 5-(3-chloro-4-fluorophenyl)-5-methyl-2-[8-(4,4,4-trifluorobutyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-3,7-dihydropyrrolo[2,3-d]pyrimidine-4,6-dione Chemical compound ClC=1C=C(C=CC=1F)C1(C(NC=2N=C(N=C(C=21)O)C=1N=C(C=2N(C=1)N=CN=2)CCCC(F)(F)F)=O)C UYOVMYULXQMQPB-UHFFFAOYSA-N 0.000 claims description 2
- ZIQMLBVGBHFJMI-UHFFFAOYSA-N 5-(4-chloro-3-fluorophenyl)-5-methyl-2-(8-propyl-[1,2,4]triazolo[1,5-a]pyrazin-6-yl)-3,7-dihydropyrrolo[2,3-d]pyrimidine-4,6-dione Chemical compound ClC1=C(C=C(C=C1)C1(C(NC=2N=C(N=C(C=21)O)C=1N=C(C=2N(C=1)N=CN=2)CCC)=O)C)F ZIQMLBVGBHFJMI-UHFFFAOYSA-N 0.000 claims description 2
- XTZHSOJLALOJRU-UHFFFAOYSA-N 5-(4-chloro-3-fluorophenyl)-5-methyl-2-[2-methyl-8-(3,3,4,4,4-pentafluorobutyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-3,7-dihydropyrrolo[2,3-d]pyrimidine-4,6-dione Chemical compound ClC1=C(C=C(C=C1)C1(C(NC=2N=C(N=C(C=21)O)C=1N=C(C=2N(C=1)N=C(N=2)C)CCC(C(F)(F)F)(F)F)=O)C)F XTZHSOJLALOJRU-UHFFFAOYSA-N 0.000 claims description 2
- GHMMCRQPZIYZHH-UHFFFAOYSA-N 5-(4-chloro-3-fluorophenyl)-5-methyl-2-[8-(3,3,3-trifluoropropyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-3,7-dihydropyrrolo[2,3-d]pyrimidine-4,6-dione Chemical compound ClC1=C(C=C(C=C1)C1(C(NC=2N=C(N=C(C=21)O)C=1N=C(C=2N(C=1)N=CN=2)CCC(F)(F)F)=O)C)F GHMMCRQPZIYZHH-UHFFFAOYSA-N 0.000 claims description 2
- BZDAFTAFNAUHAP-UHFFFAOYSA-N 5-(4-chloro-3-fluorophenyl)-5-methyl-2-[8-(3,3,4,4,4-pentafluorobutyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-3,7-dihydropyrrolo[2,3-d]pyrimidine-4,6-dione Chemical compound ClC1=C(C=C(C=C1)C1(C(NC=2N=C(N=C(C=21)O)C=1N=C(C=2N(C=1)N=CN=2)CCC(C(F)(F)F)(F)F)=O)C)F BZDAFTAFNAUHAP-UHFFFAOYSA-N 0.000 claims description 2
- VTFPIOAZLAOGIP-UHFFFAOYSA-N 5-(4-chloro-3-fluorophenyl)-5-methyl-2-[8-(4,4,4-trifluorobutyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-3,7-dihydropyrrolo[2,3-d]pyrimidine-4,6-dione Chemical compound ClC1=C(C=C(C=C1)C1(C(NC=2N=C(N=C(C=21)O)C=1N=C(C=2N(C=1)N=CN=2)CCCC(F)(F)F)=O)C)F VTFPIOAZLAOGIP-UHFFFAOYSA-N 0.000 claims description 2
- RQUJHXXCTCPMEU-UHFFFAOYSA-N 5-(4-chlorophenyl)-5-cyclopropyl-2-[8-(4,4,4-trifluorobutyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-3,7-dihydropyrrolo[2,3-d]pyrimidine-4,6-dione Chemical compound ClC1=CC=C(C=C1)C1(C(NC=2N=C(N=C(C=21)O)C=1N=C(C=2N(C=1)N=CN=2)CCCC(F)(F)F)=O)C1CC1 RQUJHXXCTCPMEU-UHFFFAOYSA-N 0.000 claims description 2
- MZQAKUBUKLVBNB-UHFFFAOYSA-N 5-(4-chlorophenyl)-5-methyl-2-(2-methyl-8-propyl-[1,2,4]triazolo[1,5-a]pyrazin-6-yl)-3,7-dihydropyrrolo[2,3-d]pyrimidine-4,6-dione Chemical compound ClC1=CC=C(C=C1)C1(C(NC=2N=C(N=C(C=21)O)C=1N=C(C=2N(C=1)N=C(N=2)C)CCC)=O)C MZQAKUBUKLVBNB-UHFFFAOYSA-N 0.000 claims description 2
- NQXKGNSTRHZFOG-UHFFFAOYSA-N 5-(4-chlorophenyl)-5-methyl-2-(8-propyl-[1,2,4]triazolo[1,5-a]pyrazin-6-yl)-3,7-dihydropyrrolo[2,3-d]pyrimidine-4,6-dione Chemical compound ClC1=CC=C(C=C1)C1(C(NC=2N=C(N=C(C=21)O)C=1N=C(C=2N(C=1)N=CN=2)CCC)=O)C NQXKGNSTRHZFOG-UHFFFAOYSA-N 0.000 claims description 2
- XVTLVBPEBCUUPH-UHFFFAOYSA-N 5-(4-chlorophenyl)-5-methyl-2-[8-(3,3,3-trifluoropropyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-3,7-dihydropyrrolo[2,3-d]pyrimidine-4,6-dione Chemical compound ClC1=CC=C(C=C1)C1(C(NC=2N=C(N=C(C=21)O)C=1N=C(C=2N(C=1)N=CN=2)CCC(F)(F)F)=O)C XVTLVBPEBCUUPH-UHFFFAOYSA-N 0.000 claims description 2
- XGSAUVJSUOHIQR-UHFFFAOYSA-N 5-(4-chlorophenyl)-5-methyl-2-[8-(3,3,4,4,4-pentafluorobutyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-3,7-dihydropyrrolo[2,3-d]pyrimidine-4,6-dione Chemical compound ClC1=CC=C(C=C1)C1(C(NC=2N=C(N=C(C=21)O)C=1N=C(C=2N(C=1)N=CN=2)CCC(C(F)(F)F)(F)F)=O)C XGSAUVJSUOHIQR-UHFFFAOYSA-N 0.000 claims description 2
- QIHQYKPCZFVCLW-UHFFFAOYSA-N 5-(4-chlorophenyl)-5-methyl-2-[8-(4,4,4-trifluorobutyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-3,7-dihydropyrrolo[2,3-d]pyrimidine-4,6-dione Chemical compound ClC1=CC=C(C=C1)C1(C(NC=2N=C(N=C(C=21)O)C=1N=C(C=2N(C=1)N=CN=2)CCCC(F)(F)F)=O)C QIHQYKPCZFVCLW-UHFFFAOYSA-N 0.000 claims description 2
- QEXQJEDNFMNQHS-UHFFFAOYSA-N 5-(4-fluorophenyl)-2-[8-[(4-fluorophenyl)methyl]-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-5-methyl-3,7-dihydropyrrolo[2,3-d]pyrimidine-4,6-dione Chemical compound FC1=CC=C(CC=2C=3N(C=C(N=2)C=2N=C(C4=C(N=2)NC(C4(C)C2=CC=C(C=C2)F)=O)O)N=CN=3)C=C1 QEXQJEDNFMNQHS-UHFFFAOYSA-N 0.000 claims description 2
- QZVDNDBVKIRAMV-UHFFFAOYSA-N 5-(4-fluorophenyl)-5-methyl-2-(8-propyl-[1,2,4]triazolo[1,5-a]pyrazin-6-yl)-3,7-dihydropyrrolo[2,3-d]pyrimidine-4,6-dione Chemical compound FC1=CC=C(C=C1)C1(C(NC=2N=C(N=C(C=21)O)C=1N=C(C=2N(C=1)N=CN=2)CCC)=O)C QZVDNDBVKIRAMV-UHFFFAOYSA-N 0.000 claims description 2
- JCAADJBKSUZCPW-UHFFFAOYSA-N 5-(4-fluorophenyl)-5-methyl-2-[2-methyl-8-(3,3,4,4,4-pentafluorobutyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-3,7-dihydropyrrolo[2,3-d]pyrimidine-4,6-dione Chemical compound FC1=CC=C(C=C1)C1(C(NC=2N=C(N=C(C=21)O)C=1N=C(C=2N(C=1)N=C(N=2)C)CCC(C(F)(F)F)(F)F)=O)C JCAADJBKSUZCPW-UHFFFAOYSA-N 0.000 claims description 2
- RVWDIFMQHHMXAP-UHFFFAOYSA-N 5-(4-fluorophenyl)-5-methyl-2-[8-(2-methylpropyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-3,7-dihydropyrrolo[2,3-d]pyrimidine-4,6-dione Chemical compound FC1=CC=C(C=C1)C1(C(NC=2N=C(N=C(C=21)O)C=1N=C(C=2N(C=1)N=CN=2)CC(C)C)=O)C RVWDIFMQHHMXAP-UHFFFAOYSA-N 0.000 claims description 2
- IAJVJHRGFMNGET-UHFFFAOYSA-N 5-(4-fluorophenyl)-5-methyl-2-[8-(2-methylpropyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-7H-pyrrolo[2,3-d]pyrimidin-6-one Chemical compound FC1=CC=C(C=C1)C1(C(NC=2N=C(N=CC=21)C=1N=C(C=2N(C=1)N=CN=2)CC(C)C)=O)C IAJVJHRGFMNGET-UHFFFAOYSA-N 0.000 claims description 2
- LNRXFHPGMNHSDF-UHFFFAOYSA-N 5-(4-fluorophenyl)-5-methyl-2-[8-(3,3,3-trifluoropropyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-3,7-dihydropyrrolo[2,3-d]pyrimidine-4,6-dione Chemical compound FC1=CC=C(C=C1)C1(C(NC=2N=C(N=C(C=21)O)C=1N=C(C=2N(C=1)N=CN=2)CCC(F)(F)F)=O)C LNRXFHPGMNHSDF-UHFFFAOYSA-N 0.000 claims description 2
- GHHUNCRUKHYJBG-UHFFFAOYSA-N 5-(4-fluorophenyl)-5-methyl-2-[8-(3,3,4,4,4-pentafluorobutyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-3,7-dihydropyrrolo[2,3-d]pyrimidine-4,6-dione Chemical compound FC1=CC=C(C=C1)C1(C(NC=2N=C(N=C(C=21)O)C=1N=C(C=2N(C=1)N=CN=2)CCC(C(F)(F)F)(F)F)=O)C GHHUNCRUKHYJBG-UHFFFAOYSA-N 0.000 claims description 2
- FNQWGAJWOVJUBS-UHFFFAOYSA-N 5-(4-fluorophenyl)-5-methyl-2-[8-(3,3,4,4,4-pentafluorobutyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-7H-pyrrolo[2,3-d]pyrimidin-6-one Chemical compound FC1=CC=C(C=C1)C1(C(NC=2N=C(N=CC=21)C=1N=C(C=2N(C=1)N=CN=2)CCC(C(F)(F)F)(F)F)=O)C FNQWGAJWOVJUBS-UHFFFAOYSA-N 0.000 claims description 2
- QMEGLEOBAWUJPM-UHFFFAOYSA-N 5-(4-fluorophenyl)-5-methyl-2-[8-(4,4,4-trifluorobutyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-3,7-dihydropyrrolo[2,3-d]pyrimidine-4,6-dione Chemical compound FC1=CC=C(C=C1)C1(C(NC=2N=C(N=C(C=21)O)C=1N=C(C=2N(C=1)N=CN=2)CCCC(F)(F)F)=O)C QMEGLEOBAWUJPM-UHFFFAOYSA-N 0.000 claims description 2
- QOJYZXIZHRERGR-UHFFFAOYSA-N 5-(4-fluorophenyl)-5-methyl-6-oxo-2-[8-(3,3,4,4,4-pentafluorobutyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-7H-pyrrolo[2,3-d]pyrimidine-4-carboxamide Chemical compound FC1=CC=C(C=C1)C1(C(NC=2N=C(N=C(C=21)C(=O)N)C=1N=C(C=2N(C=1)N=CN=2)CCC(C(F)(F)F)(F)F)=O)C QOJYZXIZHRERGR-UHFFFAOYSA-N 0.000 claims description 2
- HTSWBHXYYZTKOR-UHFFFAOYSA-N 5-(5-chloropyridin-2-yl)-5-methyl-2-[8-(3,3,4,4,4-pentafluorobutyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-3,7-dihydropyrrolo[2,3-d]pyrimidine-4,6-dione Chemical compound ClC=1C=CC(=NC=1)C1(C(NC=2N=C(N=C(C=21)O)C=1N=C(C=2N(C=1)N=CN=2)CCC(C(F)(F)F)(F)F)=O)C HTSWBHXYYZTKOR-UHFFFAOYSA-N 0.000 claims description 2
- HDQSTMUOYLADDU-UHFFFAOYSA-N 5-(5-chloropyridin-2-yl)-5-methyl-2-[8-(3,3,4,4,4-pentafluorobutyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-7H-pyrrolo[2,3-d]pyrimidin-6-one Chemical compound ClC=1C=CC(=NC=1)C1(C(NC=2N=C(N=CC=21)C=1N=C(C=2N(C=1)N=CN=2)CCC(C(F)(F)F)(F)F)=O)C HDQSTMUOYLADDU-UHFFFAOYSA-N 0.000 claims description 2
- NDBRZJKOQUYAFM-UHFFFAOYSA-N 5-(5-chloropyridin-2-yl)-5-methyl-2-[8-(4,4,4-trifluorobutyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-3,7-dihydropyrrolo[2,3-d]pyrimidine-4,6-dione Chemical compound ClC=1C=CC(=NC=1)C1(C(NC=2N=C(N=C(C=21)O)C=1N=C(C=2N(C=1)N=CN=2)CCCC(F)(F)F)=O)C NDBRZJKOQUYAFM-UHFFFAOYSA-N 0.000 claims description 2
- FQIDCQHKAQGVCE-UHFFFAOYSA-N 5-(5-fluoropyridin-2-yl)-5-methyl-2-(8-propyl-[1,2,4]triazolo[1,5-a]pyrazin-6-yl)-3,7-dihydropyrrolo[2,3-d]pyrimidine-4,6-dione Chemical compound FC=1C=CC(=NC=1)C1(C(NC=2N=C(N=C(C=21)O)C=1N=C(C=2N(C=1)N=CN=2)CCC)=O)C FQIDCQHKAQGVCE-UHFFFAOYSA-N 0.000 claims description 2
- RNLZSTFDCDPUOM-UHFFFAOYSA-N 5-(5-fluoropyridin-2-yl)-5-methyl-2-[8-(3,3,4,4,4-pentafluorobutyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-3,7-dihydropyrrolo[2,3-d]pyrimidine-4,6-dione Chemical compound FC=1C=CC(=NC=1)C1(C(NC=2N=C(N=C(C=21)O)C=1N=C(C=2N(C=1)N=CN=2)CCC(C(F)(F)F)(F)F)=O)C RNLZSTFDCDPUOM-UHFFFAOYSA-N 0.000 claims description 2
- SZKWCPXSXXZGBM-UHFFFAOYSA-N 5-(5-fluoropyridin-2-yl)-5-methyl-2-[8-(4,4,4-trifluorobutyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-3,7-dihydropyrrolo[2,3-d]pyrimidine-4,6-dione Chemical compound FC=1C=CC(=NC=1)C1(C(NC=2N=C(N=C(C=21)O)C=1N=C(C=2N(C=1)N=CN=2)CCCC(F)(F)F)=O)C SZKWCPXSXXZGBM-UHFFFAOYSA-N 0.000 claims description 2
- IRAXKEOTEXTBIZ-UHFFFAOYSA-N 5-(5-fluoropyridin-2-yl)-5-methyl-2-[8-(4,4,4-trifluorobutyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-7H-pyrrolo[2,3-d]pyrimidin-6-one Chemical compound FC=1C=CC(=NC=1)C1(C(NC=2N=C(N=CC=21)C=1N=C(C=2N(C=1)N=CN=2)CCCC(F)(F)F)=O)C IRAXKEOTEXTBIZ-UHFFFAOYSA-N 0.000 claims description 2
- XIGIDVSPIFXCAQ-UHFFFAOYSA-N 5-(5-fluoropyridin-3-yl)-5-methyl-2-[8-(3,3,4,4,4-pentafluorobutyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-3,7-dihydropyrrolo[2,3-d]pyrimidine-4,6-dione Chemical compound FC=1C=C(C=NC=1)C1(C(NC=2N=C(N=C(C=21)O)C=1N=C(C=2N(C=1)N=CN=2)CCC(C(F)(F)F)(F)F)=O)C XIGIDVSPIFXCAQ-UHFFFAOYSA-N 0.000 claims description 2
- FLSGGECKLJAXPI-UHFFFAOYSA-N 5-(5-methoxypyridin-2-yl)-5-methyl-2-[8-(4,4,4-trifluorobutyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-3,7-dihydropyrrolo[2,3-d]pyrimidine-4,6-dione Chemical compound OC=1C2=C(N=C(N=1)C=1N=C(C=3N(C=1)N=CN=3)CCCC(F)(F)F)NC(C2(C)C1=NC=C(C=C1)OC)=O FLSGGECKLJAXPI-UHFFFAOYSA-N 0.000 claims description 2
- GMFPXEDWXYMGSS-UHFFFAOYSA-N 5-cyclopropyl-2-[8-(4,4,4-trifluorobutyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-5-[4-(trifluoromethyl)phenyl]-3,7-dihydropyrrolo[2,3-d]pyrimidine-4,6-dione Chemical compound C1(CC1)C1(C(NC=2N=C(N=C(C=21)O)C=1N=C(C=2N(C=1)N=CN=2)CCCC(F)(F)F)=O)C1=CC=C(C=C1)C(F)(F)F GMFPXEDWXYMGSS-UHFFFAOYSA-N 0.000 claims description 2
- ZQPNNJBLYIUGRQ-UHFFFAOYSA-N 5-cyclopropyl-5-(3,4-difluorophenyl)-2-(8-propyl-[1,2,4]triazolo[1,5-a]pyrazin-6-yl)-3,7-dihydropyrrolo[2,3-d]pyrimidine-4,6-dione Chemical compound C1(CC1)C1(C(NC=2N=C(N=C(C=21)O)C=1N=C(C=2N(C=1)N=CN=2)CCC)=O)C1=CC(=C(C=C1)F)F ZQPNNJBLYIUGRQ-UHFFFAOYSA-N 0.000 claims description 2
- RRHBOVMYQSORJM-UHFFFAOYSA-N 5-cyclopropyl-5-(3,4-difluorophenyl)-2-[8-(3,3,4,4,4-pentafluorobutyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-3,7-dihydropyrrolo[2,3-d]pyrimidine-4,6-dione Chemical compound C1(CC1)C1(C(NC=2N=C(N=C(C=21)O)C=1N=C(C=2N(C=1)N=CN=2)CCC(C(F)(F)F)(F)F)=O)C1=CC(=C(C=C1)F)F RRHBOVMYQSORJM-UHFFFAOYSA-N 0.000 claims description 2
- AWYLFKHLOUQDCJ-UHFFFAOYSA-N 5-cyclopropyl-5-(3,4-difluorophenyl)-2-[8-(4,4,4-trifluorobutyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-3,7-dihydropyrrolo[2,3-d]pyrimidine-4,6-dione Chemical compound C1(CC1)C1(C(NC=2N=C(N=C(C=21)O)C=1N=C(C=2N(C=1)N=CN=2)CCCC(F)(F)F)=O)C1=CC(=C(C=C1)F)F AWYLFKHLOUQDCJ-UHFFFAOYSA-N 0.000 claims description 2
- UKWGKGCNJFZTMQ-UHFFFAOYSA-N 5-cyclopropyl-5-(4-fluorophenyl)-2-[8-(4,4,4-trifluorobutyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-3,7-dihydropyrrolo[2,3-d]pyrimidine-4,6-dione Chemical compound C1(CC1)C1(C(NC=2N=C(N=C(C=21)O)C=1N=C(C=2N(C=1)N=CN=2)CCCC(F)(F)F)=O)C1=CC=C(C=C1)F UKWGKGCNJFZTMQ-UHFFFAOYSA-N 0.000 claims description 2
- ZBVSGZUWUCYQDO-UHFFFAOYSA-N 5-cyclopropyl-5-(5-fluoropyridin-3-yl)-2-[8-(3,3,4,4,4-pentafluorobutyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-3,7-dihydropyrrolo[2,3-d]pyrimidine-4,6-dione Chemical compound C1(CC1)C1(C(NC=2N=C(N=C(C=21)O)C=1N=C(C=2N(C=1)N=CN=2)CCC(C(F)(F)F)(F)F)=O)C=1C=NC=C(C=1)F ZBVSGZUWUCYQDO-UHFFFAOYSA-N 0.000 claims description 2
- POEYPFCJUOEHDS-UHFFFAOYSA-N 5-cyclopropyl-6-oxo-2-[8-(3,3,4,4,4-pentafluorobutyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-5-[5-(trifluoromethyl)pyridin-2-yl]-7H-pyrrolo[2,3-d]pyrimidine-4-carboxamide Chemical compound C1(CC1)C1(C(NC=2N=C(N=C(C=21)C(=O)N)C=1N=C(C=2N(C=1)N=CN=2)CCC(C(F)(F)F)(F)F)=O)C1=NC=C(C=C1)C(F)(F)F POEYPFCJUOEHDS-UHFFFAOYSA-N 0.000 claims description 2
- FTURIAOICMDDDE-UHFFFAOYSA-N 5-methyl-2-[8-(3,3,4,4,4-pentafluorobutyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-5-phenyl-3,7-dihydropyrrolo[2,3-d]pyrimidine-4,6-dione Chemical compound OC=1C2=C(N=C(N=1)C=1N=C(C=3N(C=1)N=CN=3)CCC(C(F)(F)F)(F)F)NC(C2(C1=CC=CC=C1)C)=O FTURIAOICMDDDE-UHFFFAOYSA-N 0.000 claims description 2
- YZBBCEWESBXZLS-UHFFFAOYSA-N 5-methyl-2-[8-(3,3,4,4,4-pentafluorobutyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-5-pyridin-2-yl-3,7-dihydropyrrolo[2,3-d]pyrimidine-4,6-dione Chemical compound OC=1C2=C(N=C(N=1)C=1N=C(C=3N(C=1)N=CN=3)CCC(C(F)(F)F)(F)F)NC(C2(C1=NC=CC=C1)C)=O YZBBCEWESBXZLS-UHFFFAOYSA-N 0.000 claims description 2
- MMJJLMSPEWYVPY-UHFFFAOYSA-N 5-methyl-2-[8-(4,4,4-trifluorobutyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-5-[4-(trifluoromethyl)phenyl]-3,7-dihydropyrrolo[2,3-d]pyrimidine-4,6-dione Chemical compound OC=1C2=C(N=C(N=1)C=1N=C(C=3N(C=1)N=CN=3)CCCC(F)(F)F)NC(C2(C1=CC=C(C=C1)C(F)(F)F)C)=O MMJJLMSPEWYVPY-UHFFFAOYSA-N 0.000 claims description 2
- WQUUWICGCVWZDN-UHFFFAOYSA-N 5-methyl-5-(5-methylpyridin-2-yl)-2-[8-(3,3,4,4,4-pentafluorobutyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-3,7-dihydropyrrolo[2,3-d]pyrimidine-4,6-dione Chemical compound OC=1C2=C(N=C(N=1)C=1N=C(C=3N(C=1)N=CN=3)CCC(C(F)(F)F)(F)F)NC(C2(C1=NC=C(C=C1)C)C)=O WQUUWICGCVWZDN-UHFFFAOYSA-N 0.000 claims description 2
- AJOUZKWYHOFUBD-UHFFFAOYSA-N 5-methyl-5-(5-methylpyridin-2-yl)-2-[8-(4,4,4-trifluorobutyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-3,7-dihydropyrrolo[2,3-d]pyrimidine-4,6-dione Chemical compound OC=1C2=C(N=C(N=1)C=1N=C(C=3N(C=1)N=CN=3)CCCC(F)(F)F)NC(C2(C1=NC=C(C=C1)C)C)=O AJOUZKWYHOFUBD-UHFFFAOYSA-N 0.000 claims description 2
- MRIWGONMCZZCCX-UHFFFAOYSA-N 5-methyl-5-phenyl-2-[8-(4,4,4-trifluorobutyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-3,7-dihydropyrrolo[2,3-d]pyrimidine-4,6-dione Chemical compound OC=1C2=C(N=C(N=1)C=1N=C(C=3N(C=1)N=CN=3)CCCC(F)(F)F)NC(C2(C1=CC=CC=C1)C)=O MRIWGONMCZZCCX-UHFFFAOYSA-N 0.000 claims description 2
- AUAGWZLHYJPYQO-UHFFFAOYSA-N 5-methyl-5-pyridin-2-yl-2-[8-(4,4,4-trifluorobutyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-3,7-dihydropyrrolo[2,3-d]pyrimidine-4,6-dione Chemical compound OC=1C2=C(N=C(N=1)C=1N=C(C=3N(C=1)N=CN=3)CCCC(F)(F)F)NC(C2(C1=NC=CC=C1)C)=O AUAGWZLHYJPYQO-UHFFFAOYSA-N 0.000 claims description 2
- FJQBCLXGEBWTQJ-UHFFFAOYSA-N 5-methyl-6-oxo-2-[8-(4,4,4-trifluorobutyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-5-[5-(trifluoromethyl)pyridin-2-yl]-7H-pyrrolo[2,3-d]pyrimidine-4-carboxamide Chemical compound CC1(C(NC=2N=C(N=C(C=21)C(=O)N)C=1N=C(C=2N(C=1)N=CN=2)CCCC(F)(F)F)=O)C1=NC=C(C=C1)C(F)(F)F FJQBCLXGEBWTQJ-UHFFFAOYSA-N 0.000 claims description 2
- YJWGDEYTAGQDLX-UHFFFAOYSA-N 6-[4-amino-5-cyclopropyl-6-oxo-2-[8-(3,3,4,4,4-pentafluorobutyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-7H-pyrrolo[2,3-d]pyrimidin-5-yl]pyridine-3-carbonitrile Chemical compound NC=1C2=C(N=C(N=1)C=1N=C(C=3N(C=1)N=CN=3)CCC(C(F)(F)F)(F)F)NC(C2(C1CC1)C1=NC=C(C#N)C=C1)=O YJWGDEYTAGQDLX-UHFFFAOYSA-N 0.000 claims description 2
- ZZXQFRLDCWLXSC-UHFFFAOYSA-N 6-[4-amino-5-cyclopropyl-6-oxo-2-[8-(4,4,4-trifluorobutyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-7H-pyrrolo[2,3-d]pyrimidin-5-yl]pyridine-3-carbonitrile Chemical compound NC=1C2=C(N=C(N=1)C=1N=C(C=3N(C=1)N=CN=3)CCCC(F)(F)F)NC(C2(C1CC1)C1=NC=C(C#N)C=C1)=O ZZXQFRLDCWLXSC-UHFFFAOYSA-N 0.000 claims description 2
- UCYYTBUUTZUGSL-UHFFFAOYSA-N 6-[4-amino-5-methyl-6-oxo-2-[8-(3,3,4,4,4-pentafluorobutyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-7H-pyrrolo[2,3-d]pyrimidin-5-yl]pyridine-3-carbonitrile Chemical compound NC=1C2=C(N=C(N=1)C=1N=C(C=3N(C=1)N=CN=3)CCC(C(F)(F)F)(F)F)NC(C2(C)C1=NC=C(C#N)C=C1)=O UCYYTBUUTZUGSL-UHFFFAOYSA-N 0.000 claims description 2
- RDUDGTAYTMYFEF-UHFFFAOYSA-N 6-[4-amino-5-methyl-6-oxo-2-[8-(4,4,4-trifluorobutyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-7H-pyrrolo[2,3-d]pyrimidin-5-yl]pyridine-3-carbonitrile Chemical compound NC=1C2=C(N=C(N=1)C=1N=C(C=3N(C=1)N=CN=3)CCCC(F)(F)F)NC(C2(C)C1=NC=C(C#N)C=C1)=O RDUDGTAYTMYFEF-UHFFFAOYSA-N 0.000 claims description 2
- LBVPDJBIFFOYKB-UHFFFAOYSA-N 6-[5-methyl-4,6-dioxo-2-[8-(3,3,4,4,4-pentafluorobutyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-3,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl]pyridine-3-carbonitrile Chemical compound OC=1C2=C(N=C(N=1)C=1N=C(C=3N(C=1)N=CN=3)CCC(C(F)(F)F)(F)F)NC(C2(C)C1=NC=C(C#N)C=C1)=O LBVPDJBIFFOYKB-UHFFFAOYSA-N 0.000 claims description 2
- XDDXRBZGDMREBJ-UHFFFAOYSA-N O=C(C1)NC2=C1C=NC(C1=CN3N=CN=C3C(CCC(F)(F)F)=N1)=N2 Chemical compound O=C(C1)NC2=C1C=NC(C1=CN3N=CN=C3C(CCC(F)(F)F)=N1)=N2 XDDXRBZGDMREBJ-UHFFFAOYSA-N 0.000 claims description 2
- 239000000556 agonist Substances 0.000 claims description 2
- 239000003524 antilipemic agent Substances 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- 206010012601 diabetes mellitus Diseases 0.000 claims description 2
- 239000003937 drug carrier Substances 0.000 claims description 2
- 230000004761 fibrosis Effects 0.000 claims description 2
- 150000002632 lipids Chemical class 0.000 claims description 2
- 230000002685 pulmonary effect Effects 0.000 claims description 2
- BBCDREPRFLMMHC-UHFFFAOYSA-N 4-amino-2-(8-butyl-[1,2,4]triazolo[1,5-a]pyrazin-6-yl)-5-cyclopropyl-5-(5-fluoropyridin-2-yl)-7H-pyrrolo[2,3-d]pyrimidin-6-one Chemical compound NC=1C2=C(N=C(N=1)C=1N=C(C=3N(C=1)N=CN=3)CCCC)NC(C2(C1=NC=C(C=C1)F)C1CC1)=O BBCDREPRFLMMHC-UHFFFAOYSA-N 0.000 claims 1
- ZPHZAYGQQFNLLE-UHFFFAOYSA-N 4-amino-5-[5-(difluoromethyl)pyridin-2-yl]-5-methyl-2-[8-(4,4,4-trifluorobutyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-7H-pyrrolo[2,3-d]pyrimidin-6-one Chemical compound NC=1C2=C(N=C(N=1)C=1N=C(C=3N(C=1)N=CN=3)CCCC(F)(F)F)NC(C2(C)C1=NC=C(C=C1)C(F)F)=O ZPHZAYGQQFNLLE-UHFFFAOYSA-N 0.000 claims 1
- OEVSBRPRPGIELY-UHFFFAOYSA-N 4-amino-2-(8-butyl-[1,2,4]triazolo[1,5-a]pyrazin-6-yl)-5-cyclopropyl-5-(3,4-difluorophenyl)-7H-pyrrolo[2,3-d]pyrimidin-6-one Chemical compound NC=1C2=C(N=C(N=1)C=1N=C(C=3N(C=1)N=CN=3)CCCC)NC(C2(C1=CC(=C(C=C1)F)F)C1CC1)=O OEVSBRPRPGIELY-UHFFFAOYSA-N 0.000 description 1
- HRFHQESZAJMGCE-UHFFFAOYSA-N 4-amino-5-(3-chloro-4-fluorophenyl)-5-methyl-2-[8-(4,4,4-trifluorobutyl)-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-7H-pyrrolo[2,3-d]pyrimidin-6-one Chemical compound NC=1C2=C(N=C(N=1)C=1N=C(C=3N(C=1)N=CN=3)CCCC(F)(F)F)NC(C2(C)C1=CC(=C(C=C1)F)Cl)=O HRFHQESZAJMGCE-UHFFFAOYSA-N 0.000 description 1
- HPOHRFACRZAJPT-UHFFFAOYSA-N 4-amino-5-(4-fluorophenyl)-2-[8-[(4-fluorophenyl)methyl]-2-methyl-[1,2,4]triazolo[1,5-a]pyrazin-6-yl]-5-methyl-7H-pyrrolo[2,3-d]pyrimidin-6-one Chemical compound NC=1C2=C(N=C(N=1)C=1N=C(C=3N(C=1)N=C(N=3)C)CC1=CC=C(C=C1)F)NC(C2(C)C1=CC=C(C=C1)F)=O HPOHRFACRZAJPT-UHFFFAOYSA-N 0.000 description 1
- 0 Cc1n[n](cc(-c2nc(*)c(C(*)C(N3)=O)c3n2)nc2*)c2n1 Chemical compound Cc1n[n](cc(-c2nc(*)c(C(*)C(N3)=O)c3n2)nc2*)c2n1 0.000 description 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462082686P | 2014-11-21 | 2014-11-21 | |
| US62/082,686 | 2014-11-21 | ||
| US201562144697P | 2015-04-08 | 2015-04-08 | |
| US62/144,697 | 2015-04-08 | ||
| PCT/US2015/061442 WO2016081668A1 (en) | 2014-11-21 | 2015-11-19 | Triazolo-pyrazinyl derivatives useful as soluble guanylate cyclase activators |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2017535561A JP2017535561A (ja) | 2017-11-30 |
| JP2017535561A5 true JP2017535561A5 (Direct) | 2019-01-10 |
Family
ID=54704159
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017526957A Withdrawn JP2017535561A (ja) | 2014-11-21 | 2015-11-19 | 可溶性グアニル酸シクラーゼ活性化剤として有用なトリアゾロ−ピラジニル誘導体 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US9822130B2 (Direct) |
| EP (1) | EP3221319B1 (Direct) |
| JP (1) | JP2017535561A (Direct) |
| KR (1) | KR20170084299A (Direct) |
| CN (1) | CN107001389A (Direct) |
| AU (1) | AU2015349888A1 (Direct) |
| BR (1) | BR112017010551A2 (Direct) |
| CA (1) | CA2967965A1 (Direct) |
| MX (1) | MX2017006649A (Direct) |
| RU (1) | RU2017121278A (Direct) |
| TW (1) | TW201625635A (Direct) |
| WO (1) | WO2016081668A1 (Direct) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3079701B1 (en) | 2013-12-11 | 2021-08-11 | Merck Sharp & Dohme Corp. | Soluble guanylate cyclase activators |
| EP3079700B1 (en) | 2013-12-11 | 2020-11-25 | Merck Sharp & Dohme Corp. | Soluble guanylate cyclase activators |
| WO2015187470A1 (en) | 2014-06-04 | 2015-12-10 | Merck Sharp & Dohme Corp. | Imidazo-pyrazine derivatives useful as soluble guanylate cyclase activators |
| CA2959202A1 (en) * | 2014-08-29 | 2016-03-03 | Bayer Pharma Aktiengesellschaft | Substituted annulated pyrimidines and use thereof |
| US10245264B2 (en) | 2015-05-27 | 2019-04-02 | Merck Sharp & Dohme Corp. | Substituted imidazo[1,2-a]pyrazines as soluble guanylate cyclase activators |
| WO2016191335A1 (en) | 2015-05-28 | 2016-12-01 | Merck Sharp & Dohme Corp. | Imidazo-pyrazinyl derivatives useful as soluble guanylate cyclase activators |
| WO2017107052A1 (en) | 2015-12-22 | 2017-06-29 | Merck Sharp & Dohme Corp. | Soluble guanylate cyclase stimulators |
| WO2017197555A1 (en) * | 2016-05-16 | 2017-11-23 | Merck Sharp & Dohme Corp. | Fused pyrazine derivatives useful as soluble guanylate cyclase stimulators |
| WO2017200857A1 (en) * | 2016-05-18 | 2017-11-23 | Merck Sharp & Dohme Corp. | Methods for using triazolo-pyrazinyl soluble guanylate cyclase activators in fibrotic disorders |
| CN105968055B (zh) * | 2016-07-26 | 2018-08-28 | 中国科学院长春应用化学研究所 | 一种芳基嘧啶及其衍生物的制备方法 |
| CR20220309A (es) | 2016-09-02 | 2022-09-16 | Cyclerion Therapeutics Inc | Estimuladores de sgc |
| US10918639B2 (en) | 2016-10-11 | 2021-02-16 | Bayer Pharma Aktiengesellschaft | Combination containing SGC stimulators and mineralocorticoid receptor antagonists |
| WO2018069148A1 (de) | 2016-10-11 | 2018-04-19 | Bayer Pharma Aktiengesellschaft | Kombination enthaltend sgc aktivatoren und mineralocorticoid-rezeptor-antagonisten |
| WO2019081456A1 (en) | 2017-10-24 | 2019-05-02 | Bayer Aktiengesellschaft | USE OF SGC ACTIVATORS AND STIMULATORS COMPRISING A BETA2 SUBUNIT |
| EP3498298A1 (en) | 2017-12-15 | 2019-06-19 | Bayer AG | The use of sgc stimulators and sgc activators alone or in combination with pde5 inhibitors for the treatment of bone disorders including osteogenesis imperfecta (oi) |
| MA51305A (fr) * | 2017-12-19 | 2020-10-28 | Cyclerion Therapeutics Inc | Stimulateurs de sgc |
| CN112055584A (zh) | 2018-04-30 | 2020-12-08 | 拜耳公司 | sGC活化剂和sGC刺激剂用于治疗认知障碍的用途 |
| BR112020022340A2 (pt) | 2018-05-15 | 2021-02-02 | Bayer Aktiengesellschaft | benzamidas substituídas por 1,3-tiazol-2-il para o tratamento de doenças associadas com sensibilização de fibras nervosas |
| EP3574905A1 (en) | 2018-05-30 | 2019-12-04 | Adverio Pharma GmbH | Method of identifying a subgroup of patients suffering from dcssc which benefits from a treatment with sgc stimulators and sgc activators in a higher degree than a control group |
| WO2020148379A1 (en) | 2019-01-17 | 2020-07-23 | Bayer Aktiengesellschaft | Methods to determine whether a subject is suitable of being treated with an agonist of soluble guanylyl cyclase (sgc) |
| CN115515963B (zh) * | 2020-04-30 | 2025-08-01 | 正大天晴药业集团股份有限公司 | 嘧啶三并环类化合物及其应用 |
| CR20230532A (es) * | 2021-04-20 | 2024-03-22 | Tisento Therapeutics Inc | ESTIMULADORES DE GUANILIL CICLASA SOLUBLE (sGC) |
| JP2024516623A (ja) | 2021-04-20 | 2024-04-16 | ティセント セラピューティクス インコーポレーテッド | ｓＧＣ刺激剤でのＣＮＳ疾患の処置 |
| WO2024086182A1 (en) | 2022-10-18 | 2024-04-25 | Tisento Therapeutics Inc. | Treatment of mitochondrial diseases with sgc stimulators |
| CN116768868B (zh) * | 2023-08-15 | 2023-12-08 | 云南省药物研究所 | 一种哒嗪酮硫代衍生物及其制备方法和应用 |
Family Cites Families (59)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4845079A (en) | 1985-01-23 | 1989-07-04 | Luly Jay R | Peptidylaminodiols |
| US5066643A (en) | 1985-02-19 | 1991-11-19 | Sandoz Ltd. | Fluorine and chlorine statine or statone containing peptides and method of use |
| US4894437A (en) | 1985-11-15 | 1990-01-16 | The Upjohn Company | Novel renin inhibiting polypeptide analogs containing S-aryl-D- or L- or DL-cysteinyl, 3-(arylthio)lactic acid or 3-(arylthio)alkyl moieties |
| US4885292A (en) | 1986-02-03 | 1989-12-05 | E. R. Squibb & Sons, Inc. | N-heterocyclic alcohol renin inhibitors |
| US4980283A (en) | 1987-10-01 | 1990-12-25 | Merck & Co., Inc. | Renin-inhibitory pepstatin phenyl derivatives |
| US5089471A (en) | 1987-10-01 | 1992-02-18 | G. D. Searle & Co. | Peptidyl beta-aminoacyl aminodiol carbamates as anti-hypertensive agents |
| US5034512A (en) | 1987-10-22 | 1991-07-23 | Warner-Lambert Company | Branched backbone renin inhibitors |
| US5063207A (en) | 1987-10-26 | 1991-11-05 | Warner-Lambert Company | Renin inhibitors, method for using them, and compositions containing them |
| US5055466A (en) | 1987-11-23 | 1991-10-08 | E. R. Squibb & Sons, Inc. | N-morpholino derivatives and their use as anti-hypertensive agents |
| US5036054A (en) | 1988-02-11 | 1991-07-30 | Warner-Lambert Company | Renin inhibitors containing alpha-heteroatom amino acids |
| US5036053A (en) | 1988-05-27 | 1991-07-30 | Warner-Lambert Company | Diol-containing renin inhibitors |
| DE3841520A1 (de) | 1988-12-09 | 1990-06-13 | Hoechst Ag | Enzymhemmende harnstoffderivate von dipeptiden, verfahren zu ihrer herstellung, diese enthaltende mittel und ihre verwendung |
| US5106835A (en) | 1988-12-27 | 1992-04-21 | American Cyanamid Company | Renin inhibitors |
| US5063208A (en) | 1989-07-26 | 1991-11-05 | Abbott Laboratories | Peptidyl aminodiol renin inhibitors |
| US5098924A (en) | 1989-09-15 | 1992-03-24 | E. R. Squibb & Sons, Inc. | Diol sulfonamide and sulfinyl renin inhibitors |
| US5104869A (en) | 1989-10-11 | 1992-04-14 | American Cyanamid Company | Renin inhibitors |
| US5114937A (en) | 1989-11-28 | 1992-05-19 | Warner-Lambert Company | Renin inhibiting nonpeptides |
| US5075451A (en) | 1990-03-08 | 1991-12-24 | American Home Products Corporation | Pyrrolimidazolones useful as renin inhibitors |
| US5095119A (en) | 1990-03-08 | 1992-03-10 | American Home Products Corporation | Renin inhibitors |
| US5064965A (en) | 1990-03-08 | 1991-11-12 | American Home Products Corporation | Renin inhibitors |
| US5071837A (en) | 1990-11-28 | 1991-12-10 | Warner-Lambert Company | Novel renin inhibiting peptides |
| AU6691798A (en) | 1997-03-07 | 1998-09-22 | Metabasis Therapeutics, Inc. | Novel indole and azaindole inhibitors of fructose-1,6-bisphosphatase |
| EP0970095B1 (en) | 1997-03-07 | 2003-10-29 | Metabasis Therapeutics, Inc. | Novel benzimidazole inhibitors of fructose-1,6-bisphosphatase |
| AU6452098A (en) | 1997-03-07 | 1998-09-22 | Metabasis Therapeutics, Inc. | Novel purine inhibitors of fructose-1,6-bisphosphatase |
| DE19744027A1 (de) | 1997-10-06 | 1999-04-08 | Hoechst Marion Roussel De Gmbh | Substituierte Pyrazolo[3,4-b]pyridine, ihre Herstellung und Verwendung in Arzneimitteln |
| DE19744026A1 (de) | 1997-10-06 | 1999-04-08 | Hoechst Marion Roussel De Gmbh | Pyrazol-Derivate, ihre Herstellung und ihre Verwendung in Arzneimitteln |
| DE19834044A1 (de) | 1998-07-29 | 2000-02-03 | Bayer Ag | Neue substituierte Pyrazolderivate |
| US6489476B1 (en) | 1998-09-09 | 2002-12-03 | Metabasis Therapeutics, Inc. | Heteroaromatic compounds containing a phosphonate group that are inhibitors of fructose-1,6-bisphosphatase |
| ATE362468T1 (de) | 2000-07-25 | 2007-06-15 | Merck & Co Inc | N-substituierte indole mit anwendung in der behandlung von diabetes |
| CA2434491A1 (en) | 2001-01-30 | 2002-08-08 | Merck & Co., Inc. | Acyl sulfamides for treatment of obesity, diabetes and lipid disorders |
| DE10220570A1 (de) | 2002-05-08 | 2003-11-20 | Bayer Ag | Carbamat-substituierte Pyrazolopyridine |
| AR040241A1 (es) | 2002-06-10 | 2005-03-23 | Merck & Co Inc | Inhibidores de la 11-beta-hidroxiesteroide deshidrogrenasa 1 para el tratamiento de la diabetes obesidad y dislipidemia |
| BR0313825A (pt) | 2002-08-29 | 2005-07-12 | Merck & Co Inc | Composto, composição farmacêutica, método para tratar de diabete mellitus tipo 2 em um mamìfero, e, uso de composto |
| WO2004019869A2 (en) | 2002-08-29 | 2004-03-11 | Merck & Co., Inc. | Indoles having anti-diabetic activity |
| AU2004207444B2 (en) | 2003-01-17 | 2008-07-31 | Merck & Co., Inc. | N-cyclohexylaminocarbonyl benzenesulfonamide derivatives |
| EA200600372A1 (ru) | 2003-09-05 | 2006-08-25 | Ньюроджин Корпорейшн | Конденсированные с гетероарилом пиридины, пиразины и пиримидины в качестве лигандов рецептора кортикотропин-рилизинг-фактора (crf 1) |
| JP2010531307A (ja) | 2007-06-28 | 2010-09-24 | メルク フロスト カナダ リミテツド | Ｇｐｒ１０５活性のアンタゴニストとしての置換縮合ピリミジン |
| WO2009001836A1 (en) | 2007-06-28 | 2008-12-31 | Semiconductor Energy Laboratory Co., Ltd. | Manufacturing method of semiconductor device |
| BRPI0814939A2 (pt) | 2007-08-10 | 2015-01-27 | Glaxosmithkline Llc | Entidade química, composição farmacêutica, e, método para tratar uma infecção viral em um mamífero. |
| BRPI0816382A2 (pt) | 2007-09-06 | 2015-02-24 | Merck Sharp & Dohme | Composto, composição, e, métodos para ativar a guanilato ciclase solúvel e para tratar ou previnir doenças |
| WO2009042053A2 (en) | 2007-09-21 | 2009-04-02 | Merck & Co., Inc. | Neuromedin u receptor agonists and uses thereof |
| AU2009322836B2 (en) | 2008-11-25 | 2013-04-04 | Merck Sharp & Dohme Corp. | Soluble guanylate cyclase activators |
| EP2401265B1 (en) | 2009-02-26 | 2016-09-14 | Merck Sharp & Dohme Corp. | Derivatives of 1-pyri(mid)in-2-yl-pyrazole-4-carboxylic acid which are useful for therapy or prophylaxis of cardiovascular diseases |
| GB0917934D0 (en) | 2009-10-13 | 2009-11-25 | Syngenta Ltd | Herbicidal compounds |
| TW201200518A (en) | 2010-03-10 | 2012-01-01 | Kalypsys Inc | Heterocyclic inhibitors of histamine receptors for the treatment of disease |
| US9284301B2 (en) | 2010-03-25 | 2016-03-15 | Merck Sharp & Dohme Corp. | Soluble guanylate cyclase activators |
| DE102010021637A1 (de) | 2010-05-26 | 2011-12-01 | Bayer Schering Pharma Aktiengesellschaft | Substituierte 5-Fluor-1H-Pyrazolopyridine und ihre Verwendung |
| EA023254B1 (ru) * | 2010-05-27 | 2016-05-31 | Мерк Шарп Энд Домэ Корп. | Активаторы растворимой гуанилатциклазы |
| CA2804470A1 (en) | 2010-07-09 | 2012-01-12 | Bayer Intellectual Property Gmbh | Ring-fused pyrimidines and triazines and use thereof for the treatment and/or prophylaxis of cardiovascular diseases |
| US8895583B2 (en) | 2010-10-28 | 2014-11-25 | Merck Sharp & Dohme Corp. | Soluble guanylate cyclase activators |
| ES2583086T3 (es) | 2011-04-21 | 2016-09-19 | Bayer Intellectual Property Gmbh | Pirazolopiridinas sustituidas con fluoroalquilo y su uso |
| CN103649093B (zh) | 2011-05-06 | 2017-07-07 | 拜耳知识产权有限责任公司 | 取代的咪唑并吡啶和咪唑并哒嗪及其用途 |
| US20140228366A1 (en) | 2011-07-06 | 2014-08-14 | Bayer Intellectual Property Gmbh | Heteroaryl-substituted pyrazolopyridines and use thereof as soluble guanylate cyclase stimulators |
| PE20141582A1 (es) | 2011-09-02 | 2014-11-06 | Bayer Ip Gmbh | Pirimidinas anilladas sustituidas y uso de las mismas |
| DE102012200352A1 (de) | 2012-01-11 | 2013-07-11 | Bayer Intellectual Property Gmbh | Substituierte, annellierte Imidazole und Pyrazole und ihre Verwendung |
| DE102012200349A1 (de) | 2012-01-11 | 2013-07-11 | Bayer Intellectual Property Gmbh | Substituierte annellierte Pyrimidine und Triazine und ihre Verwendung |
| EP3079700B1 (en) | 2013-12-11 | 2020-11-25 | Merck Sharp & Dohme Corp. | Soluble guanylate cyclase activators |
| EP3079701B1 (en) | 2013-12-11 | 2021-08-11 | Merck Sharp & Dohme Corp. | Soluble guanylate cyclase activators |
| WO2015187470A1 (en) | 2014-06-04 | 2015-12-10 | Merck Sharp & Dohme Corp. | Imidazo-pyrazine derivatives useful as soluble guanylate cyclase activators |
-
2015
- 2015-11-13 TW TW104137596A patent/TW201625635A/zh unknown
- 2015-11-19 KR KR1020177016515A patent/KR20170084299A/ko not_active Withdrawn
- 2015-11-19 AU AU2015349888A patent/AU2015349888A1/en not_active Abandoned
- 2015-11-19 RU RU2017121278A patent/RU2017121278A/ru not_active Application Discontinuation
- 2015-11-19 US US14/945,576 patent/US9822130B2/en active Active
- 2015-11-19 WO PCT/US2015/061442 patent/WO2016081668A1/en not_active Ceased
- 2015-11-19 CN CN201580063273.3A patent/CN107001389A/zh active Pending
- 2015-11-19 MX MX2017006649A patent/MX2017006649A/es unknown
- 2015-11-19 BR BR112017010551A patent/BR112017010551A2/pt not_active Application Discontinuation
- 2015-11-19 CA CA2967965A patent/CA2967965A1/en not_active Abandoned
- 2015-11-19 EP EP15801104.9A patent/EP3221319B1/en active Active
- 2015-11-19 JP JP2017526957A patent/JP2017535561A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017535561A5 (Direct) | ||
| RU2017121278A (ru) | Триазоло-пиразинильные производные, применимые в качестве растворимых активаторов гуанилатциклазы | |
| JP2022184886A5 (Direct) | ||
| JP2020527560A5 (Direct) | ||
| JP5789288B2 (ja) | 可溶性グアニル酸シクラーゼアクチベーター | |
| JP5911638B2 (ja) | ベンゾチアゾール−６−イル酢酸誘導体およびｈｉｖ感染を処置するためのそれらの使用 | |
| JP2016520116A5 (Direct) | ||
| JP7654071B2 (ja) | 複素環スピロ化合物及び使用方法 | |
| US20180099975A1 (en) | Compounds for kinase modulation, and indications therefor | |
| JP2019503337A5 (Direct) | ||
| RU2012130436A (ru) | Новое антитромботическое средство | |
| JP2004525149A5 (Direct) | ||
| RU2017112518A (ru) | Пиридоновые и азапиридоновые соединения и способы применения | |
| RU2665036C2 (ru) | Гетероароматические соединения-модуляторы фосфоинозидит-3-киназы и способы применения | |
| JP2020007357A (ja) | 有機化合物 | |
| EP3004109A1 (en) | Imidazopyrrolidinone derivatives and their use in the treatment of disease | |
| JP2018515525A5 (Direct) | ||
| RU2672910C2 (ru) | Гетероароматические соединения как модуляторы фосфоинозитид-3-киназы | |
| JP2013523884A5 (Direct) | ||
| KR20150096769A (ko) | 키나제 조절을 위한 화합물 및 방법, 및 그에 대한 적응증 | |
| JP2013522354A5 (Direct) | ||
| JP2018529731A5 (Direct) | ||
| JP2016537384A5 (Direct) | ||
| WO2015049574A1 (en) | 4-azaindole derivatives | |
| EP3668858A1 (en) | Pyrazolo[1,5-a]pyrazin-4-yl and related derivatives |